bcr_patient_barcode	bcr_drug_barcode	days_to_drug_therapy_end	days_to_drug_therapy_start	days_to_drug_treatment_end	days_to_drug_treatment_start	dosage_units	drug_category	drug_dosage	drug_name	initial_course	number_cycles	prescribed_dose	prescribed_dose_units	regimen_indication	regimen_number	route_of_administration	therapy_ongoing	therapy_type	therapy_type_notes	total_dose	total_dose_units
TCGA-02-0001	TCGA-02-0001-D22170	277	92	null	null	null	null	null	Celebrex	null	4	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	400	mg
TCGA-02-0001	TCGA-02-0001-D22171	277	92	null	null	null	null	null	CRA	null	4	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	75	mg/m2
TCGA-02-0001	TCGA-02-0001-D22172	null	null	null	null	null	null	null	Cis Retinoic Acid	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0001	TCGA-02-0001-D22173	null	null	null	null	null	null	null	Celebrex	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0003	TCGA-02-0003-D22177	94	49	null	null	null	null	null	Tamoxifen	null	1	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	80	mg
TCGA-02-0004	TCGA-02-0004-D22181	153	44	null	null	null	null	null	Temozolomide	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-02-0004	TCGA-02-0004-D22182	153	44	null	null	null	null	null	Temozolomide	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-02-0006	TCGA-02-0006-D22186	148	88	null	null	null	null	null	Temozolomide	null	7	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	200	mg/m2
TCGA-02-0006	TCGA-02-0006-D22187	null	null	null	null	null	null	null	CIS Retinoic Acid	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0006	TCGA-02-0006-D22188	null	null	null	null	null	null	null	Temozolomide	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0007	TCGA-02-0007-D22192	338	33	null	null	null	null	null	Temozolomide	null	5	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2/day
TCGA-02-0007	TCGA-02-0007-D22193	338	33	null	null	null	null	null	Temozolomide	null	5	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0010	TCGA-02-0010-D22199	569	509	null	null	null	null	null	Temozolomide	null	2	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	200	mg/m2
TCGA-02-0010	TCGA-02-0010-D22200	null	null	null	null	null	null	null	CPT 11	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0010	TCGA-02-0010-D22201	null	null	null	null	null	null	null	Thalidomide	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0011	TCGA-02-0011-D22205	144	20	null	null	null	null	null	Temozolomide	null	4	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-02-0011	TCGA-02-0011-D22206	144	20	null	null	null	null	null	Temozolomide	null	4	null	null	null	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-02-0011	TCGA-02-0011-D22207	null	null	null	null	null	null	null	Carboplatin	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0011	TCGA-02-0011-D22208	null	null	null	null	null	null	null	Iressa	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0014	TCGA-02-0014-D22212	null	2348	null	null	null	null	null	Anti necplatens	null	null	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-02-0014	TCGA-02-0014-D22213	null	null	null	null	null	null	null	Temozolomide	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0015	TCGA-02-0015-D22217	null	0	null	null	null	null	null	Gliadel Wafer	null	null	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	1	null
TCGA-02-0015	TCGA-02-0015-D22218	null	null	null	null	null	null	null	AE 788	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0016	TCGA-02-0016-D22222	1041	83	null	null	null	null	null	Temozolomide	null	30	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-02-0021	TCGA-02-0021-D22226	190	72	null	null	null	null	null	Temozolomide	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2/day
TCGA-02-0021	TCGA-02-0021-D22227	null	null	null	null	null	null	null	6 Thiguanine	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0021	TCGA-02-0021-D22228	null	null	null	null	null	null	null	CCNU	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0021	TCGA-02-0021-D22229	null	null	null	null	null	null	null	Xeloda	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0021	TCGA-02-0021-D22230	null	null	null	null	null	null	null	Celebrex	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0023	TCGA-02-0023-D22234	34	-9	null	null	null	null	null	Temozolomide	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0023	TCGA-02-0023-D22235	null	null	null	null	null	null	null	Temozolomide	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0024	TCGA-02-0024-D22239	701	151	null	null	null	null	null	Temozolomide	null	18	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	3600	mg/m2
TCGA-02-0025	TCGA-02-0025-D22243	656	118	null	null	null	null	null	Temozolomide	null	18	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	200	mg/m2/day
TCGA-02-0025	TCGA-02-0025-D22244	null	null	null	null	null	null	null	Sarasar	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0025	TCGA-02-0025-D22245	null	null	null	null	null	null	null	Temozolomide	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0026	TCGA-02-0026-D22249	418	92	null	null	null	null	null	Temozolomide	null	11	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2/day
TCGA-02-0026	TCGA-02-0026-D22250	null	null	null	null	null	null	null	Gleevec	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0026	TCGA-02-0026-D22251	null	null	null	null	null	null	null	Hydroxyurea	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0027	TCGA-02-0027-D22255	256	27	null	null	null	null	null	Temozolomide	null	6	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	1200	mg/m2/day
TCGA-02-0027	TCGA-02-0027-D22256	null	null	null	null	null	null	null	6 Thiguanine	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0027	TCGA-02-0027-D22257	null	null	null	null	null	null	null	CCNU	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0027	TCGA-02-0027-D22258	null	null	null	null	null	null	null	Xeloda	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0027	TCGA-02-0027-D22259	null	null	null	null	null	null	null	Celebrex	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0028	TCGA-02-0028-D22263	2304	1939	null	null	null	null	null	Temozolomide	null	12	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	200	mg/m2
TCGA-02-0028	TCGA-02-0028-D22264	null	null	null	null	null	null	null	Celebrex	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0028	TCGA-02-0028-D22265	null	null	null	null	null	null	null	Temozolomide	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0028	TCGA-02-0028-D22266	null	null	null	null	null	null	null	Xeloda	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0034	TCGA-02-0034-D22272	159	89	null	null	null	null	null	Temozolomide	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2/day
TCGA-02-0038	TCGA-02-0038-D22278	173	112	null	null	null	null	null	Tanceva	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/day
TCGA-02-0043	TCGA-02-0043-D22284	359	297	null	null	null	null	null	CCNU	null	2	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	100	mg/m2
TCGA-02-0043	TCGA-02-0043-D22285	null	null	null	null	null	null	null	6 Thiguanine	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0043	TCGA-02-0043-D22286	null	null	null	null	null	null	null	CCNU	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0043	TCGA-02-0043-D22287	null	null	null	null	null	null	null	Xeloda	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0043	TCGA-02-0043-D22288	null	null	null	null	null	null	null	Celebrex	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0052	TCGA-02-0052-D22300	204	34	null	null	null	null	null	Temozolomide	null	5	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2/day
TCGA-02-0054	TCGA-02-0054-D22304	73	28	null	null	null	null	null	Temozolomide	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0054	TCGA-02-0054-D22305	null	null	null	null	null	null	null	6 Thiguanine	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0054	TCGA-02-0054-D22306	null	null	null	null	null	null	null	CCNU	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0054	TCGA-02-0054-D22307	null	null	null	null	null	null	null	Xeloda	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0054	TCGA-02-0054-D22308	null	null	null	null	null	null	null	Celebrex	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0055	TCGA-02-0055-D22312	0	-111	null	null	null	null	null	Temozolomide	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0055	TCGA-02-0055-D22313	0	-111	null	null	null	null	null	Temozolomide	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2/day
TCGA-02-0057	TCGA-02-0057-D22317	null	1	null	null	null	null	null	Gliadel Wafer	null	null	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	1	null
TCGA-02-0057	TCGA-02-0057-D22318	null	null	null	null	null	null	null	Temozolomide	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0058	TCGA-02-0058-D22322	142	20	null	null	null	null	null	Temozomide	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0060	TCGA-02-0060-D22328	182	15	null	null	null	null	null	Temozolomide	null	3	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-02-0060	TCGA-02-0060-D22329	182	15	null	null	null	null	null	Temozolomide	null	3	null	null	null	null	Oral	NO	Chemotherapy	null	600	mg/m2/day
TCGA-02-0064	TCGA-02-0064-D22333	358	23	null	null	null	null	null	Temozolomide	null	12	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2/day
TCGA-02-0064	TCGA-02-0064-D22334	null	null	null	null	null	null	null	CPT 11	null	null	null	null	RECURRENCE	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-02-0064	TCGA-02-0064-D22335	null	null	null	null	null	null	null	Bevacizumab	null	null	null	null	RECURRENCE	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-02-0068	TCGA-02-0068-D22339	179	14	null	null	null	null	null	Temozolomide	null	3	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-02-0068	TCGA-02-0068-D22340	179	14	null	null	null	null	null	Temozolomide	null	3	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0068	TCGA-02-0068-D22341	null	null	null	null	null	null	null	CPT 11	null	null	null	null	RECURRENCE	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-02-0068	TCGA-02-0068-D22342	null	null	null	null	null	null	null	Bevacizumab	null	null	null	null	RECURRENCE	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-02-0069	TCGA-02-0069-D22346	945	15	null	null	null	null	null	Temozolomide	null	24	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2/day
TCGA-02-0069	TCGA-02-0069-D22347	945	15	null	null	null	null	null	Temozolomide	null	24	null	null	null	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0070	TCGA-02-0070-D22351	57	10	null	null	null	null	null	Temozolomide	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0074	TCGA-02-0074-D22357	154	13	null	null	null	null	null	Temozolomide	null	3	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0074	TCGA-02-0074-D22358	154	13	null	null	null	null	null	Temozolomide	null	3	null	null	null	null	Oral	NO	Chemotherapy	null	200	mg/m2/day
TCGA-02-0075	TCGA-02-0075-D22362	36	16	null	null	null	null	null	Temozolomide	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-02-0080	TCGA-02-0080-D22368	443	352	null	null	null	null	null	Temozolomide	null	4	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	100	mg/m2/day
TCGA-02-0080	TCGA-02-0080-D22369	null	null	null	null	null	null	null	CIS Retinoic Acid	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0083	TCGA-02-0083-D22373	404	68	null	null	null	null	null	Temozolomide	null	11	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	200	mg/m2
TCGA-02-0085	TCGA-02-0085-D22379	785	740	null	null	null	null	null	Temozolomide	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0086	TCGA-02-0086-D22383	85	13	null	null	null	null	null	Temozolomide	null	2	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	75	mg/m2
TCGA-02-0086	TCGA-02-0086-D22384	null	null	null	null	null	null	null	6 Thiguanine	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-02-0086	TCGA-02-0086-D22385	null	null	null	null	null	null	null	CCNU	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-02-0086	TCGA-02-0086-D22386	null	null	null	null	null	null	null	Xeloda	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-02-0086	TCGA-02-0086-D22387	null	null	null	null	null	null	null	Celebrex	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-02-0089	TCGA-02-0089-D22393	282	67	null	null	null	null	null	Temozolomide	null	7	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1400	mg/m2
TCGA-02-0099	TCGA-02-0099-D22397	-124	-260	null	null	null	null	null	Temozolomide	null	3	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2/day
TCGA-02-0099	TCGA-02-0099-D22398	null	null	null	null	null	null	null	Temozolomide	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0102	TCGA-02-0102-D22402	402	157	null	null	null	null	null	Procarbizine	null	5	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	60	mg/m2/day
TCGA-02-0102	TCGA-02-0102-D22403	402	157	null	null	null	null	null	CCNU	null	5	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	110	mg/m2/day
TCGA-02-0102	TCGA-02-0102-D22404	402	157	null	null	null	null	null	Vincristine	null	5	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	1.4	mg/m2/day
TCGA-02-0104	TCGA-02-0104-D22408	1786	1536	null	null	null	null	null	Temozolomide	null	9	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-02-0104	TCGA-02-0104-D22409	1786	1536	null	null	null	null	null	Temozolomide	null	9	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2/day
TCGA-02-0106	TCGA-02-0106-D22413	175	15	null	null	null	null	null	Temozolomide	null	5	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-02-0106	TCGA-02-0106-D22414	175	15	null	null	null	null	null	Temozolomide	null	5	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	500	mg/m2/day
TCGA-02-0106	TCGA-02-0106-D22415	null	null	null	null	null	null	null	IL 13	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0107	TCGA-02-0107-D22419	130	100	null	null	null	null	null	Temozolomide	null	1	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	200	mg/m2
TCGA-02-0111	TCGA-02-0111-D22423	74	28	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	ug/m2
TCGA-02-0113	TCGA-02-0113-D22427	2627	1929	null	null	null	null	null	Temozolomide	null	24	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	4800	mg/m2
TCGA-02-0114	TCGA-02-0114-D22431	196	75	null	null	null	null	null	Procarbazine	null	4	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	60	mg/m2/day
TCGA-02-0114	TCGA-02-0114-D22432	196	75	null	null	null	null	null	CCNU	null	4	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	110	mg/m2/day
TCGA-02-0114	TCGA-02-0114-D22433	196	84	null	null	null	null	null	Vincristine	null	4	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	1.4	mg/m2/day
TCGA-02-0114	TCGA-02-0114-D22434	null	null	null	null	null	null	null	Carboplatin	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0114	TCGA-02-0114-D22435	null	null	null	null	null	null	null	Tarceva	null	null	null	null	RECURRENCE	null	null	null	Chemotherapy	null	null	null
TCGA-02-0115	TCGA-02-0115-D22439	107	27	null	null	null	null	null	Temozolomide	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-02-0115	TCGA-02-0115-D22440	null	null	null	null	null	null	null	Bevacizumab	null	null	null	null	RECURRENCE	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-02-0116	TCGA-02-0116-D22444	388	53	null	null	null	null	null	Temozolomide	null	12	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	900	mg/m2
TCGA-02-0116	TCGA-02-0116-D22445	null	null	null	null	null	null	null	Gleevec	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0116	TCGA-02-0116-D22446	null	null	null	null	null	null	null	Hydoxyurea	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0289	TCGA-02-0289-D22464	181	93	null	null	null	null	null	Procarbazine	null	2	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	60	mg/m2
TCGA-02-0289	TCGA-02-0289-D22465	181	93	null	null	null	null	null	CCNU	null	2	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	110	mg/m2
TCGA-02-0289	TCGA-02-0289-D22466	181	93	null	null	null	null	null	Vincristine	null	2	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	1.4	mg/m2/day
TCGA-02-0290	TCGA-02-0290-D22470	3942	502	null	null	null	null	null	Procarbazine	null	5	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	60	mg/m2
TCGA-02-0290	TCGA-02-0290-D22471	3942	502	null	null	null	null	null	CCNU	null	5	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	110	mg/m2
TCGA-02-0290	TCGA-02-0290-D22472	3942	502	null	null	null	null	null	Vincristine	null	5	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	1.4	mg/m2
TCGA-02-0317	TCGA-02-0317-D22476	176	23	null	null	null	null	null	anti neopastons	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-02-0325	TCGA-02-0325-D22484	115	84	null	null	null	null	null	Procarbazine	null	1	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	60	mg/m2
TCGA-02-0325	TCGA-02-0325-D22485	115	84	null	null	null	null	null	CCNU	null	1	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	110	mg/m2
TCGA-02-0325	TCGA-02-0325-D22486	115	84	null	null	null	null	null	Vincristine	null	1	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	1.4	mg/m2
TCGA-02-0325	TCGA-02-0325-D22487	null	null	null	null	null	null	null	CIS Retinoic Acid	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	null
TCGA-02-0330	TCGA-02-0330-D22493	137	107	null	null	null	null	null	Procarbazine	null	01	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	60	mg/m2
TCGA-02-0330	TCGA-02-0330-D22494	137	107	null	null	null	null	null	CCNU	null	1	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	110	mg/m2
TCGA-02-0330	TCGA-02-0330-D22495	137	107	null	null	null	null	null	Vincristine	null	1	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	1.4	mg/m2
TCGA-02-0330	TCGA-02-0330-D22496	null	null	null	null	null	null	null	VP-16	null	null	null	null	RECURRENCE	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-02-0330	TCGA-02-0330-D22497	null	null	null	null	null	null	null	Carboplatin	null	null	null	null	RECURRENCE	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-02-0332	TCGA-02-0332-D22501	229	98	null	null	null	null	null	procarbazine	null	4	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	60	mg/m2
TCGA-02-0332	TCGA-02-0332-D22502	229	98	null	null	null	null	null	CCNU	null	04	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	110	mg/m2
TCGA-02-0332	TCGA-02-0332-D22503	229	98	null	null	null	null	null	Vincristine	null	4	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	1.4	mg/m2
TCGA-02-0337	TCGA-02-0337-D22509	428	185	null	null	null	null	null	Procarbazine	null	5	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	60	mg/m2/day
TCGA-02-0337	TCGA-02-0337-D22510	434	185	null	null	null	null	null	CCNU	null	5	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	110	mg/m2/day
TCGA-02-0337	TCGA-02-0337-D22511	428	185	null	null	null	null	null	Vincristine	null	5	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	1.4	mg/m2/day
TCGA-02-0432	TCGA-02-0432-D22523	329	104	null	null	null	null	null	CCNU	null	6	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	100	mg/m2
TCGA-02-0440	TCGA-02-0440-D22529	288	269	null	null	null	null	null	Cis-retinoic acid	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	ug/m2
TCGA-02-2466	TCGA-02-2466-C1	71	28	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-02-2466	TCGA-02-2466-C2	102	72	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-02-2470	TCGA-02-2470-C1	98	57	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-02-2470	TCGA-02-2470-C2	182	99	null	null	null	CHEMO	null	Temodar	null	3.0	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-02-2483	TCGA-02-2483-C1	93	53	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-02-2483	TCGA-02-2483-C2	465	94	null	null	null	CHEMO	null	Temodar	null	12.0	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-02-2485	TCGA-02-2485-C1	91	51	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-02-2485	TCGA-02-2485-C2	185	92	null	null	null	CHEMO	null	Temodar	null	4.0	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-02-2486	TCGA-02-2486-C1	66	24	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-02-2486	TCGA-02-2486-C2	440	67	null	null	null	CHEMO	null	Temodar	null	12.0	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-02-2486	TCGA-02-2486-C3	229	129	null	null	null	CHEMO	null	Accutane	null	4.0	null	null	PROGRESSION	null	ORAL	NO	null	null	null	mg
TCGA-06-0124	TCGA-06-0124-D22567	1400	1066	null	null	null	null	null	temozolomide	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-06-0125	TCGA-06-0125-D22570	452	28	null	null	null	null	null	Temozolomide	null	14	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	300	mg
TCGA-06-0125	TCGA-06-0125-D22571	944	883	null	null	null	null	null	CPT 11	null	2	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	566	mg
TCGA-06-0125	TCGA-06-0125-D22572	1352	1035	null	null	null	null	null	Thalidomide	null	11	null	null	null	null	Oral	NO	Chemotherapy	null	200	mg
TCGA-06-0127	TCGA-06-0127-D22579	64	21	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0128	TCGA-06-0128-D22585	455	427	null	null	null	null	null	Temozolomide	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	285	mg
TCGA-06-0128	TCGA-06-0128-D22586	515	486	null	null	null	null	null	BCNU	null	1	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	382	mg
TCGA-06-0128	TCGA-06-0128-D22587	648	600	null	null	null	null	null	Tamoxifen	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	18	mg
TCGA-06-0128	TCGA-06-0128-D22583	175	26	null	null	null	null	null	Suramin	null	13	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-06-0128	TCGA-06-0128-D22584	396	211	null	null	null	null	null	MGI 114	null	6	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	11	mg/m2
TCGA-06-0129	TCGA-06-0129-D22592	119	14	null	null	null	null	null	Temozolomide	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	null	null
TCGA-06-0129	TCGA-06-0129-D22593	237	182	null	null	null	null	null	IL-13PE	null	null	null	null	null	null	null	NO	Immunotherapy	null	19.5	mL
TCGA-06-0130	TCGA-06-0130-D22597	280	74	null	null	null	null	null	Temozolomide	null	08	null	null	RECURRENCE	null	Oral	NO	Chemotherapy	null	null	null
TCGA-06-0133	TCGA-06-0133-D22603	53	14	null	null	null	null	null	Temozolomide	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-06-0133	TCGA-06-0133-D22604	53	14	null	null	null	null	null	EMD 121974	null	02	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	200	mg
TCGA-06-0133	TCGA-06-0133-D22605	426	79	null	null	null	null	null	CPT 11	null	10	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	263	mg
TCGA-06-0133	TCGA-06-0133-D22606	426	79	null	null	null	null	null	Avastin	null	10	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	927	mg
TCGA-06-0137	TCGA-06-0137-D22610	636	636	null	null	null	null	null	Gliadel Wafer	null	1	null	null	RECURRENCE	null	Oral	NO	Chemotherapy	null	null	null
TCGA-06-0139	TCGA-06-0139-D22615	275	203	null	null	null	null	null	CPT11	null	3	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	265	mg
TCGA-06-0139	TCGA-06-0139-D22616	275	203	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	910	mg
TCGA-06-0141	TCGA-06-0141-D22619	144	19	null	null	null	null	null	CAI NABIT 9712	null	02	250	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	250	mg
TCGA-06-0141	TCGA-06-0141-D22620	215	153	null	null	null	null	null	Temozolomide	null	02	200	mg	null	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0141	TCGA-06-0141-D22621	270	235	null	null	null	null	null	Procarbazine	null	02	170	mg/day	null	null	Oral	NO	Chemotherapy	null	170	mg/day
TCGA-06-0145	TCGA-06-0145-D22627	50	24	null	null	null	null	null	Pyrazinamide	null	01	871	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	1524	mg
TCGA-06-0146	TCGA-06-0146-D22630	315	16	null	null	null	null	null	Carmustine (BCNU)	null	06	200	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	480	mg
TCGA-06-0146	TCGA-06-0146-D22631	315	16	null	null	null	null	null	Cisplatin	null	06	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-0147	TCGA-06-0147-D22635	0	0	null	null	null	null	null	Gliadel Wafer	null	01	4	{Wafer}	ADJUVANT	null	Intratumoral	NO	Chemotherapy	null	4	{Wafer}
TCGA-06-0147	TCGA-06-0147-D22636	60	60	null	null	null	null	null	Carmustine (BCNU)	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0147	TCGA-06-0147-D22637	121	90	null	null	null	null	null	Tamoxifen	null	02	10	mg/day	null	null	Oral	NO	Chemotherapy	null	10	mg/day
TCGA-06-0147	TCGA-06-0147-D22638	395	152	null	null	null	null	null	Temozolomide	null	09	null	null	null	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0152	TCGA-06-0152-D22648	null	null	null	null	null	null	null	Paclitaxel	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0152	TCGA-06-0152-D22649	305	275	null	null	null	null	null	Carmustine	null	01	80	mg	null	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0152	TCGA-06-0152-D22650	305	305	null	null	null	null	null	Procarbazine	null	01	110	mg	null	null	Oral	NO	Chemotherapy	null	200	mg
TCGA-06-0152	TCGA-06-0152-D22651	305	305	null	null	null	null	null	Tamoxifen	null	01	10	mg	null	null	Oral	NO	Chemotherapy	null	20	mg
TCGA-06-0154	TCGA-06-0154-D22655	88	12	null	null	null	null	null	CI 980	null	04	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-0154	TCGA-06-0154-D22656	180	149	null	null	null	null	null	Carmustine	null	01	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	mg
TCGA-06-0154	TCGA-06-0154-D22657	234	234	null	null	null	null	null	Gliadel wafer	null	01	8	{Wafer}	null	null	Intratumoral	NO	Chemotherapy	null	8	{Wafer}
TCGA-06-0154	TCGA-06-0154-D22658	null	373	null	null	null	null	null	Procarbazine	null	null	100	mg	null	null	Oral	NO	Chemotherapy	null	150	mg
TCGA-06-0155	TCGA-06-0155-D22663	245	153	null	null	null	null	null	BCNU	null	02	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	80	mg/m2
TCGA-06-0155	TCGA-06-0155-D22664	257	257	null	null	null	null	null	Gliadel Wafer	null	1	null	null	PALLIATIVE	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-06-0155	TCGA-06-0155-D22665	214	184	null	null	null	null	null	Carmustine	null	02	80	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0155	TCGA-06-0155-D22666	61	9	null	null	null	null	null	CI980	null	null	null	null	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	400	mg/m2
TCGA-06-0156	TCGA-06-0156-D22670	152	60	null	null	null	null	null	Tamoxifen	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-06-0158	TCGA-06-0158-D22677	153	92	null	null	null	null	null	Carmustin	null	02	null	null	null	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0162	TCGA-06-0162-D22681	61	0	null	null	null	null	null	CAI (NABTT 9712)	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0166	TCGA-06-0166-D22687	60	14	null	null	null	null	null	Oxaliplatin	null	04	85	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-0168	TCGA-06-0168-D22691	76	28	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg
TCGA-06-0168	TCGA-06-0168-D22692	457	136	null	null	null	null	null	Temozolomide	null	10	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	380	mg
TCGA-06-0168	TCGA-06-0168-D22693	518	487	null	null	null	null	null	Carmustine	null	02	200	mg	null	null	Oral	NO	Chemotherapy	null	380	mg
TCGA-06-0169	TCGA-06-0169-D22698	78	29	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0171	TCGA-06-0171-D22702	180	81	null	null	null	null	null	Temozolomide	null	03	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	400	mg
TCGA-06-0171	TCGA-06-0171-D22703	272	230	null	null	null	null	null	Carmustine (BCNU)	null	02	200	mg	null	null	Intravenous (IV)	NO	Chemotherapy	null	394	mg
TCGA-06-0174	TCGA-06-0174-D22709	30	0	null	null	null	null	null	Tipfarnib (R115777)	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0175	TCGA-06-0175-D22713	30	15	null	null	null	null	null	Tipifarnib (R115777)	null	01	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0176	TCGA-06-0176-D19253	92	50	null	null	null	null	null	Temozolomide	null	01	75	mg/m2	null	01	Oral	NO	Chemotherapy	null	Unknown	mg
TCGA-06-0176	TCGA-06-0176-D19254	577	120	null	null	null	null	null	Temozolomide	null	12	200	mg/m2	null	01	Oral	NO	Chemotherapy	null	400	mg
TCGA-06-0178	TCGA-06-0178-D20892	95	51	null	null	null	null	null	Temozolomide	null	01	200	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	400	mg
TCGA-06-0178	TCGA-06-0178-D20893	759	121	null	null	null	null	null	Temozolomide	null	24	200	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	400	mg
TCGA-06-0178	TCGA-06-0178-D20894	2704	2530	null	null	null	null	null	MEDT 575	null	02	25	mg/kg	null	02	Oral	NO	Chemotherapy	null	2340	mg
TCGA-06-0178	TCGA-06-0178-D20895	2614	2572	null	null	null	null	null	Bevcizumab	null	02	10	mg/kg	null	03	Intravenous (IV)	NO	Targeted Molecular therapy	null	909	mg
TCGA-06-0184	TCGA-06-0184-D19258	72	23	null	null	null	null	null	Temozolomide	null	01	75	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	150	mg
TCGA-06-0184	TCGA-06-0184-D19259	669	92	null	null	null	null	null	Temozolomide	null	22	200	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	440	mg
TCGA-06-0184	TCGA-06-0184-D19260	1645	1310	null	null	null	null	null	Temozolomide	null	12	75	mg/m2	null	02	Oral	NO	Chemotherapy	null	160	mg
TCGA-06-0185	TCGA-06-0185-D19264	56	19	null	null	null	null	null	Arsenic Trioxide (ATO)	null	12	0.25	mg/kg	ADJUVANT	01	Intravenous (IV)	NO	Targeted Molecular therapy	null	17.25	mg
TCGA-06-0185	TCGA-06-0185-D19265	242	91	null	null	null	null	null	Temozolomide	null	06	200	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	370	mg
TCGA-06-0185	TCGA-06-0185-D19266	1397	739	null	null	null	null	null	Bevacizumab	null	24	10	mg/kg	null	02	Intravenous (IV)	NO	Targeted Molecular therapy	null	689	mg
TCGA-06-0185	TCGA-06-0185-D19267	1397	739	null	null	null	null	null	Irinotecan	null	24	125	mg/m2	null	02	Intravenous (IV)	NO	Chemotherapy	null	232	mg
TCGA-06-0185	TCGA-06-0185-D19268	1636	1502	null	null	null	null	null	XL184	null	02	75	mg/day	null	03	Oral	NO	Chemotherapy	null	75	mg/day
TCGA-06-0185	TCGA-06-0185-D19269	null	1664	null	null	null	null	null	Bevacizumab	null	Ongoing	10	mg/kg	null	04	Intravenous (IV)	YES	Targeted Molecular therapy	null	791	mg
TCGA-06-0185	TCGA-06-0185-D19270	2221	1979	null	null	null	null	null	Temozolomide	null	10	75	mg/m2	null	05	Oral	NO	Chemotherapy	null	145	mg
TCGA-06-0185	TCGA-06-0185-D19271	null	2252	null	null	null	null	null	Lomustine	null	04	110	mg/m2	null	06	Oral	YES	Chemotherapy	null	Unknown	mg
TCGA-06-0188	TCGA-06-0188-D20856	68	27	null	null	null	null	null	Temozolomide	null	01	75	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	140	mg
TCGA-06-0188	TCGA-06-0188-D20857	304	92	null	null	null	null	null	Temozolomide	null	08	200	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	380	mg
TCGA-06-0188	TCGA-06-0188-D20858	949	334	null	null	null	null	null	Erlotinib	null	22	75	mg/day	null	02	Oral	NO	Chemotherapy	null	75	mg/day
TCGA-06-0188	TCGA-06-0188-D20859	949	334	null	null	null	null	null	Sorafenib	null	22	200	mg/day	null	02	Oral	NO	Chemotherapy	null	200	mg/day
TCGA-06-0188	TCGA-06-0188-D20860	1230	965	null	null	null	null	null	Irinotecan	null	08	125	mg/m2	null	03	Intravenous (IV)	NO	Chemotherapy	null	254	mg
TCGA-06-0188	TCGA-06-0188-D20862	1342	965	null	null	null	null	null	Bevacizumab	null	12	10	mg/kg	null	03	Intravenous (IV)	NO	Targeted Molecular therapy	null	864	mg
TCGA-06-0188	TCGA-06-0188-D20863	1341	1244	null	null	null	null	null	Temozolomide	null	02	75	mg/m2	null	4	Oral	NO	Chemotherapy	null	150	mg
TCGA-06-0188	TCGA-06-0188-D20864	1342	1342	null	null	null	null	null	Etoposide	null	01	75	mg/m2	null	05	Oral	NO	Chemotherapy	null	50	mg
TCGA-06-0192	TCGA-06-0192-D20869	59	18	null	null	null	null	null	Temozolomide	null	01	75	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	150	mg
TCGA-06-0192	TCGA-06-0192-D20870	454	88	null	null	null	null	null	Temozolomide	null	12	200	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	420	mg
TCGA-06-0192	TCGA-06-0192-D20871	766	725	null	null	null	null	null	Lomustine	null	02	160	mg	null	02	Oral	NO	Chemotherapy	null	160	mg
TCGA-06-0192	TCGA-06-0192-D20872	807	725	null	null	null	null	null	Cediranib/Placebo	null	02	20	mg/day	null	02	Oral	NO	Targeted Molecular therapy	null	20	mg/day
TCGA-06-0192	TCGA-06-0192-D20873	1152	815	null	null	null	null	null	Bevacizumab	null	10	10	mg/kg	null	03	Intravenous (IV)	NO	Targeted Molecular therapy	null	873	mg
TCGA-06-0192	TCGA-06-0192-D20875	906	815	null	null	null	null	null	Irinotecan	null	03	125	mg/m2	null	03	Intravenous (IV)	NO	Chemotherapy	null	262.5	null
TCGA-06-0192	TCGA-06-0192-D20876	972	911	null	null	null	null	null	Temozolomide	null	02	75	mg/m2	null	04	Oral	NO	Chemotherapy	null	140	mg
TCGA-06-0195	TCGA-06-0195-D22743	182	95	null	null	null	null	null	Procarbazine	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0195	TCGA-06-0195-D22744	182	95	null	null	null	null	null	Lomustine	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0195	TCGA-06-0195-D22745	182	95	null	null	null	null	null	Vincristine	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0195	TCGA-06-0195-D22746	214	182	null	null	null	null	null	VP 16 (Etoposide)	null	01	null	null	null	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0195	TCGA-06-0195-D22747	214	182	null	null	null	null	null	Carboplatin	null	01	null	null	null	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0197	TCGA-06-0197-D22751	79	26	null	null	null	null	null	Taxol	null	03	175	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-0206	TCGA-06-0206-D22756	151	151	null	null	null	null	null	Carmustine (BCNU)	null	01	200	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-0208	TCGA-06-0208-D22760	90	31	null	null	null	null	null	Cisplatin	null	02	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-0208	TCGA-06-0208-D22761	90	31	null	null	null	null	null	Carmustine (BCNU)	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0211	TCGA-06-0211-D22771	44	25	null	null	null	null	null	CI-980	null	02	4.0	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-0211	TCGA-06-0211-D22772	212	151	null	null	null	null	null	Carmustine	null	02	null	null	null	null	null	NO	Chemotherapy	null	null	mg
TCGA-06-0211	TCGA-06-0211-D22773	221	221	null	null	null	null	null	Gliadel wafer	null	01	8	{Wafer}	null	null	Intratumoral	NO	Chemotherapy	null	8	{Wafer}
TCGA-06-0214	TCGA-06-0214-D22779	52	18	null	null	null	null	null	CI-980	null	02	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-0214	TCGA-06-0214-D22780	334	122	null	null	null	null	null	Carmustine (BCNU)	null	06	200	mg	null	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0214	TCGA-06-0214-D22781	456	334	null	null	null	null	null	Tamoxifen	null	04	10	mg/day	null	null	Oral	NO	Chemotherapy	null	10	mg/day
TCGA-06-0216	TCGA-06-0216-D22785	90	29	null	null	null	null	null	CI 980	null	04	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0216	TCGA-06-0216-D22786	456	244	null	null	null	null	null	Temozolomide	null	07	150	mg	null	null	Oral	NO	Chemotherapy	null	280	mg
TCGA-06-0216	TCGA-06-0216-D22787	580	580	null	null	null	null	null	Carmustine	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	null	meq
TCGA-06-0221	TCGA-06-0221-D22794	245	0	null	null	null	null	null	CAI (NABTT 97212)	null	08	250	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	250	mg/day
TCGA-06-0221	TCGA-06-0221-D22795	280	280	null	null	null	null	null	Gliadel Wafer	null	01	6	{Wafer}	null	null	Intratumoral	NO	Chemotherapy	null	6	{Wafer}
TCGA-06-0221	TCGA-06-0221-D22796	285	280	null	null	null	null	null	06-BG (NABTT 0803)	null	01	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-06-0221	TCGA-06-0221-D22797	457	304	null	null	null	null	null	Temozolomide	null	06	null	null	null	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0221	TCGA-06-0221-D22798	457	365	null	null	null	null	null	Reinoid/CIS retinoic acid	null	04	null	null	null	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-0221	TCGA-06-0221-D22799	488	457	null	null	null	null	null	Vatalanib (PTK787)	null	01	null	null	null	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0221	TCGA-06-0221-D22800	518	488	null	null	null	null	null	Carmustine (BCNU)	null	01	null	null	null	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0221	TCGA-06-0221-D22801	518	488	null	null	null	null	null	06-BG	null	01	null	null	null	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0241	TCGA-06-0241-D20954	81	15	null	null	null	null	null	Cilengitide	null	01	2000	mg	ADJUVANT	01	Intravenous (IV)	NO	Targeted Molecular therapy	null	4000	mg
TCGA-06-0241	TCGA-06-0241-D20955	192	84	null	null	null	null	null	Cilengitide	null	04	2000	mg	ADJUVANT	01	Intravenous (IV)	NO	Targeted Molecular therapy	null	1600	mg
TCGA-06-0241	TCGA-06-0241-D20956	81	15	null	null	null	null	null	Temozolomide	null	01	140	mg/day	ADJUVANT	01	Oral	NO	Chemotherapy	null	140	mg/day
TCGA-06-0241	TCGA-06-0241-D20957	192	84	null	null	null	null	null	Temozolomide	null	04	390	mg/day	ADJUVANT	01	Oral	NO	Chemotherapy	null	390	mg/day
TCGA-06-0241	TCGA-06-0241-D20958	728	477	null	null	null	null	null	Irinotecan	null	17	125	mg/m2	null	02	Intravenous (IV)	NO	Chemotherapy	null	773	mg
TCGA-06-0241	TCGA-06-0241-D20959	799	203	null	null	null	null	null	Bevacizumab	null	20	10	mg/kg	null	02	Intravenous (IV)	NO	Targeted Molecular therapy	null	773	mg
TCGA-06-0241	TCGA-06-0241-D20960	1370	1311	null	null	null	null	null	Temozolomide	null	03	100	mg/m2	null	03	Oral	NO	Chemotherapy	null	140	mg
TCGA-06-0241	TCGA-06-0241-D20961	1435	1043	null	null	null	null	null	Bevacizumab	null	10	10	mg/kg	null	05	Intravenous (IV)	NO	Targeted Molecular therapy	null	822	mg
TCGA-06-0394	TCGA-06-0394-D22811	121	90	null	null	null	null	null	Estramustine	null	01	null	null	null	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0394	TCGA-06-0394-D22812	121	90	null	null	null	null	null	Vincristine	null	01	null	null	null	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0394	TCGA-06-0394-D22813	121	90	null	null	null	null	null	6 Thioguanine	null	01	null	null	null	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0394	TCGA-06-0394-D22814	273	150	null	null	null	null	null	Carmustine	null	04	80	mg	null	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-0397	TCGA-06-0397-D22818	182	126	null	null	null	null	null	Procarbazine	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0397	TCGA-06-0397-D22819	182	126	null	null	null	null	null	Lomustine	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0397	TCGA-06-0397-D22820	182	126	null	null	null	null	null	Vincristine	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0409	TCGA-06-0409-D22826	149	61	null	null	null	null	null	Hyroxyurea	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-06-0409	TCGA-06-0409-D22827	334	168	null	null	null	null	null	Procarbazine	null	04	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0409	TCGA-06-0409-D22828	334	168	null	null	null	null	null	Lomustine	null	04	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0409	TCGA-06-0409-D22829	334	168	null	null	null	null	null	Vincristine	null	04	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0409	TCGA-06-0409-D22830	457	365	null	null	null	null	null	9 immunoamino camptnetecin	null	06	null	null	null	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0409	TCGA-06-0409-D22831	1267	1267	null	null	null	null	null	Gliadel Wafer	null	01	Intratumoral	{Wafer}	null	null	Intratumoral	NO	Chemotherapy	null	Intratumoral	{Wafer}
TCGA-06-0409	TCGA-06-0409-D22832	1765	1280	null	null	null	null	null	Tamoxifen	null	19	20	mg	null	null	Oral	NO	Chemotherapy	null	140	mg
TCGA-06-0409	TCGA-06-0409-D22833	1614	1280	null	null	null	null	null	Procarbazine	null	12	50	mg	null	null	Oral	NO	Chemotherapy	null	100	mg
TCGA-06-0409	TCGA-06-0409-D22834	2100	1845	null	null	null	null	null	Irinotecan	null	04	125	mg	null	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-0412	TCGA-06-0412-D22841	null	null	null	null	null	null	null	Taxol	null	01	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0412	TCGA-06-0412-D22842	153	122	null	null	null	null	null	9AC 9 Aminocamplotecian	null	01	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0412	TCGA-06-0412-D22843	274	153	null	null	null	null	null	Carmustine	null	02	null	null	null	null	null	NO	Chemotherapy	null	null	null
TCGA-06-0414	TCGA-06-0414-D22849	370	5	null	null	null	null	null	BCNU	null	4	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-06-0414	TCGA-06-0414-D22850	370	5	null	null	null	null	null	Cisplatain	null	4	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-06-0644	TCGA-06-0644-D20899	65	23	null	null	null	null	null	Temozolomide	null	01	75	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	165	mg
TCGA-06-0644	TCGA-06-0644-D20900	263	106	null	null	null	null	null	Irinotecan	null	05	125	mg/m2	null	02	Intravenous (IV)	NO	Chemotherapy	null	270	mg
TCGA-06-0644	TCGA-06-0644-D20901	333	96	null	null	null	null	null	Bevacizumab	null	07	10	mg/kg	null	02	Intravenous (IV)	NO	Targeted Molecular therapy	null	986	mg
TCGA-06-0644	TCGA-06-0644-D20902	305	274	null	null	null	null	null	Temozolomide	null	02	75	mg/m2	null	03	Oral	NO	Chemotherapy	null	190	mg
TCGA-06-0650	TCGA-06-0650-D23089	67	26	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg
TCGA-06-0650	TCGA-06-0650-D23090	355	95	null	null	null	null	null	Temozolomide	null	04	150	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	230	mg
TCGA-06-0650	TCGA-06-0650-D23091	389	389	null	null	null	null	null	Lomustine	null	01	160	mg	null	null	Oral	NO	Chemotherapy	null	160	mg
TCGA-06-0650	TCGA-06-0650-D23092	431	389	null	null	null	null	null	AZD	null	01	20	mg/day	null	null	Oral	NO	Chemotherapy	null	20	mg/day
TCGA-06-0650	TCGA-06-0650-D23093	512	486	null	null	null	null	null	Erlotinib	null	01	150	mg/day	null	null	Oral	NO	Chemotherapy	null	150	mg/day
TCGA-06-0650	TCGA-06-0650-D23094	559	515	null	null	null	null	null	Irinotecan	null	02	125	mg	null	null	Intravenous (IV)	NO	Chemotherapy	null	200	mg
TCGA-06-0650	TCGA-06-0650-D23095	669	577	null	null	null	null	null	Temozolomide	null	03	100	mg	null	null	Oral	NO	Chemotherapy	null	160	mg
TCGA-06-0650	TCGA-06-0650-D23096	657	515	null	null	null	null	null	Bevacizumab	null	null	10	mg	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	614	mg
TCGA-06-0686	TCGA-06-0686-D29584	59	25	null	null	null	null	null	A4QN	null	1	750	mg/m2	ADJUVANT	01	Intravenous (IV)	NO	Targeted Molecular therapy	null	1875	mg
TCGA-06-0686	TCGA-06-0686-D29189	65	29	null	null	null	null	null	Temozolomide	null	01	75	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	185	mg
TCGA-06-0686	TCGA-06-0686-D29190	126	94	null	null	null	null	null	Temozolomide	null	02	150	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	380	mg
TCGA-06-0686	TCGA-06-0686-D29191	65	25	null	null	null	null	null	A4QN	null	01	150	mg/m2	ADJUVANT	01	Intravenous (IV)	NO	Targeted Molecular therapy	null	1876	mg
TCGA-06-0686	TCGA-06-0686-D29192	278	174	null	null	null	null	null	AT 101	null	04	20	mg/day	null	02	Oral	NO	Targeted Molecular therapy	null	20	mg
TCGA-06-0686	TCGA-06-0686-D29193	366	304	null	null	null	null	null	Erlotinib (Tarceva)	null	02	150	mg/day	null	03	Oral	NO	Chemotherapy	null	150	mg/day
TCGA-06-0686	TCGA-06-0686-D29194	412	384	null	null	null	null	null	Irintotecan	null	1.5	125	mg/m2	null	04	Intravenous (IV)	NO	Chemotherapy	null	312	mg
TCGA-06-0686	TCGA-06-0686-D29195	412	412	null	null	null	null	null	Bevacizumab	null	.5	10	mg/kg	null	04	Intravenous (IV)	NO	Targeted Molecular therapy	null	1182	mg
TCGA-06-0744	TCGA-06-0744-D20887	119	89	null	null	null	null	null	Temozolomide	null	01	75	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	190	mg
TCGA-06-0744	TCGA-06-0744-D20888	485	119	null	null	null	null	null	Temozolomide	null	12	150	mg/m2	ADJUVANT	01	Oral	NO	Chemotherapy	null	380	mg
TCGA-06-0875	TCGA-06-0875-D22878	null	null	null	null	null	null	null	Temozolomide	null	null	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	135	mg
TCGA-06-0876	TCGA-06-0876-D22882	271	98	null	null	null	null	null	Temozolomide	null	5	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	350	mg
TCGA-06-0878	TCGA-06-0878-D22889	53	0	null	null	null	null	null	Temodar	null	1	null	null	null	null	Oral	null	Chemotherapy	null	145	mg
TCGA-06-0878	TCGA-06-0878-D22890	null	78	null	null	null	null	null	Irinotecan	null	5	null	null	ADJUVANT	null	Intravenous (IV)	YES	Chemotherapy	null	242	mg
TCGA-06-0878	TCGA-06-0878-D22891	null	78	null	null	null	null	null	Avastin	null	5	null	null	ADJUVANT	null	Intravenous (IV)	YES	Chemotherapy	null	811	mg
TCGA-06-0879	TCGA-06-0879-D22895	null	67	null	null	null	null	null	Temozolomide	null	3	null	null	ADJUVANT	null	Oral	YES	Chemotherapy	null	200	mg
TCGA-06-0879	TCGA-06-0879-D22896	null	84	null	null	null	null	null	dcVax	null	null	null	null	ADJUVANT	null	null	YES	Targeted Molecular therapy	null	null	null
TCGA-06-0881	TCGA-06-0881-D22900	133	72	null	null	null	null	null	Temodar	null	2	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	140	mg
TCGA-06-0881	TCGA-06-0881-D22901	null	150	null	null	null	null	null	Avastin	null	2	null	null	null	null	Intravenous (IV)	YES	Chemotherapy	null	747.7	mg
TCGA-06-0881	TCGA-06-0881-D22902	null	150	null	null	null	null	null	Irinotecan	null	2	null	null	ADJUVANT	null	Intravenous (IV)	YES	Chemotherapy	null	250	mg
TCGA-06-0882	TCGA-06-0882-D22906	null	160	null	null	null	null	null	Temozolomide	null	null	null	null	ADJUVANT	null	Oral	YES	Chemotherapy	null	300	mg
TCGA-06-0939	TCGA-06-0939-D18621	609	378	null	null	null	null	null	Irinotecan	null	05	125	mg/m2	null	02	Intravenous (IV)	NO	Chemotherapy	null	175	mg
TCGA-06-0939	TCGA-06-0939-D18622	665	378	null	null	null	null	null	Bevacizumab	null	10	10	mg/kg	null	02	Intravenous (IV)	NO	Targeted Molecular therapy	null	516	mg
TCGA-06-1084	TCGA-06-1084-D18613	288	246	null	null	null	null	null	Irinotecan	null	02	125	mg/m2	null	02	Intravenous (IV)	NO	Chemotherapy	null	337	mg
TCGA-06-1084	TCGA-06-1084-D18614	323	242	null	null	null	null	null	Bevacizumab	null	03	10	mg	null	02	Intravenous (IV)	NO	Targeted Molecular therapy	null	1455	mg
TCGA-06-1084	TCGA-06-1084-D18617	334	304	null	null	null	null	null	Temozolomide	null	01	null	null	null	03	Oral	NO	Chemotherapy	null	180	mg
TCGA-06-1084	TCGA-06-1084-D18618	549	445	null	null	null	null	null	Doxil	null	04	30	mg/m2	null	04	Intravenous (IV)	NO	Chemotherapy	null	81	mg
TCGA-06-1084	TCGA-06-1084-D22912	212	92	null	null	null	null	null	Temozolomide	null	04	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	500	mg
TCGA-06-1084	TCGA-06-1084-D22913	323	242	null	null	null	null	null	Avastin	null	null	10	mg	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	1455	mg
TCGA-06-1086	TCGA-06-1086-D22918	182	61	null	null	null	null	null	Temozolomide	null	3	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	400	mg
TCGA-06-1087	TCGA-06-1087-D22922	75	18	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-06-1800	TCGA-06-1800-D22926	272	92	null	null	null	null	null	Temodar	null	06	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	400	mg
TCGA-06-1801	TCGA-06-1801-D18590	243	92	null	null	null	null	null	Temodar	null	05	150	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	280	mg
TCGA-06-1801	TCGA-06-1801-D18597	323	238	null	null	null	null	null	Irinotecan	null	03	125	mg/m2	null	02	Intravesical	NO	Chemotherapy	null	227	null
TCGA-06-1801	TCGA-06-1801-D18604	323	238	null	null	null	null	null	Bevacizumab	null	03	10	mg/kg	null	02	Intravenous (IV)	NO	Targeted Molecular therapy	null	850	mg
TCGA-06-1802	TCGA-06-1802-D18607	380	97	null	null	null	null	null	Irinotecan	null	10	125	mg/m2	null	02	Intravenous (IV)	NO	Chemotherapy	null	646	mg
TCGA-06-1802	TCGA-06-1802-D18608	436	97	null	null	null	null	null	Bevacizumab	null	11	10	mg/kg	null	02	Intravenous (IV)	NO	Chemotherapy	null	845	mg
TCGA-06-1802	TCGA-06-1802-D18609	426	426	null	null	null	null	null	Temozolomide	null	01	75	mg/m2	null	03	Oral	NO	Chemotherapy	null	140	mg
TCGA-06-1805	TCGA-06-1805-D22934	null	30	null	null	null	null	null	Temodar	null	03	null	null	ADJUVANT	null	Oral	YES	Chemotherapy	null	200	mg/m2
TCGA-06-2559	TCGA-06-2559-C1	48	27	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	100	mg
TCGA-06-2561	TCGA-06-2561-C1	null	171	null	null	null	CHEMO	null	irinotecan	null	null	null	null	PROGRESSION	null	INTRAVENOUS (IV)	YES	null	null	201.25	mg
TCGA-06-2561	TCGA-06-2561-C2	null	171	null	null	null	CHEMO	null	Avastin	null	null	null	null	PROGRESSION	null	INTRAVENOUS (IV)	YES	null	null	618	mg
TCGA-06-2561	TCGA-06-2561-C3	63	21	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	120	mg
TCGA-06-2561	TCGA-06-2561-C4	148	119	null	null	null	CHEMO	null	XL 184	null	2.0	null	null	PROGRESSION	null	ORAL	NO	null	null	125	mg
TCGA-06-2562	TCGA-06-2562-C1	37	26	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	140	mg
TCGA-06-2563	TCGA-06-2563-C1	57	27	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	120	mg
TCGA-06-2564	TCGA-06-2564-C1	null	null	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	null	null	null	null	null
TCGA-06-2565	TCGA-06-2565-C1	63	16	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	75	mg
TCGA-06-2565	TCGA-06-2565-C2	153	92	null	null	null	CHEMO	null	Temodar	null	2.0	null	null	ADJUVANT	null	ORAL	NO	null	null	320	mg
TCGA-06-2565	TCGA-06-2565-C3	153	123	null	null	null	CHEMO	null	XL 184	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	75	mg
TCGA-06-2565	TCGA-06-2565-C4	null	193	null	null	null	CHEMO	null	Avastin	null	null	null	null	PROGRESSION	null	INTRAVENOUS (IV)	YES	null	null	550	mg
TCGA-06-2566	TCGA-06-2566-C1	69	30	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg
TCGA-06-2566	TCGA-06-2566-C2	100	95	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	295	mg
TCGA-06-2567	TCGA-06-2567-C1	null	null	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	null	null	null	null	null
TCGA-06-2570	TCGA-06-2570-C1	61	19	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	130	mg
TCGA-06-2570	TCGA-06-2570-C2	null	92	null	null	null	CHEMO	null	Temodar	null	8.0	null	null	ADJUVANT	null	ORAL	YES	null	null	350	mg
TCGA-06-5408	TCGA-06-5408-D22993	151	92	null	null	null	null	null	BS1-201	null	02	9.5	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	652	mg
TCGA-06-5408	TCGA-06-5408-D22994	334	151	null	null	null	null	null	Avastin	null	null	10	mg	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	680	mg
TCGA-06-5408	TCGA-06-5408-D22992	151	92	null	null	null	null	null	Temozolomide	null	2	200	mg/dL	ADJUVANT	null	Oral	NO	Chemotherapy	null	360	mg/dL
TCGA-06-5411	TCGA-06-5411-D23000	213	91	null	null	null	null	null	Temozolomide	null	4	200	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	300	mg/m2
TCGA-06-5411	TCGA-06-5411-D23001	234	212	null	null	null	null	null	Avastin	null	null	10	mg	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	726	mg
TCGA-06-5412	TCGA-06-5412-D23006	61	61	null	null	null	null	null	Temozolomide	null	1	200	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	300	mg/m2
TCGA-06-5412	TCGA-06-5412-D23007	23	14	null	null	null	null	null	ABTC 0603 Hydroxychloroquine	null	.5	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-06-5413	TCGA-06-5413-D23011	183	91	null	null	null	null	null	Temozolomide	null	3	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	340	mg
TCGA-06-5413	TCGA-06-5413-D23012	null	261	null	null	null	null	null	Avastin	null	null	10	mg	null	null	Intravenous (IV)	YES	Targeted Molecular therapy	null	1059	mg
TCGA-06-5414	TCGA-06-5414-D23016	112	41	null	null	null	null	null	Temozolomide	null	3	160	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	160	mg
TCGA-06-5414	TCGA-06-5414-D23017	124	41	null	null	null	null	null	Hydrochoroquine	null	3	600	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	600	mg
TCGA-06-5415	TCGA-06-5415-D23021	null	91	null	null	null	null	null	Temozolomide	null	null	200	mg/m2	ADJUVANT	null	Oral	YES	Chemotherapy	null	370	mg/m2
TCGA-06-5416	TCGA-06-5416-D23025	null	92	null	null	null	null	null	Temozolomide	null	null	150	mg/m2	ADJUVANT	null	Oral	YES	Chemotherapy	null	250	mg/m2
TCGA-06-5417	TCGA-06-5417-D23029	null	62	null	null	null	null	null	Temodar	null	null	150	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	225	mg
TCGA-06-5858	TCGA-06-5858-D23037	68	25	null	null	null	null	null	Temozolomide	null	1	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg
TCGA-06-5858	TCGA-06-5858-D23038	92	92	null	null	null	null	null	ABT-888 Parp Inhibitor	null	01	10	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	20	mg
TCGA-06-5858	TCGA-06-5858-D23039	null	195	null	null	null	null	null	Carboplatin	null	null	3	mg	null	null	Intravenous (IV)	YES	Chemotherapy	null	274	mg
TCGA-06-5858	TCGA-06-5858-D23040	null	195	null	null	null	null	null	Bevacizumab	null	null	10	mg	null	null	Intravenous (IV)	YES	Targeted Molecular therapy	null	1014	mg
TCGA-06-5859	TCGA-06-5859-D23044	42	13	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	180	mg
TCGA-06-5859	TCGA-06-5859-D23045	null	59	null	null	null	null	null	Temozolomide	null	null	200	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	460	mg
TCGA-06-6388	TCGA-06-6388-D23049	89	89	null	null	null	null	null	Temozolomide	null	01	150	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	300	mg
TCGA-06-6388	TCGA-06-6388-D23050	62	21	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	125	mg
TCGA-06-6388	TCGA-06-6388-D23051	null	119	null	null	null	null	null	Temozolomide	null	01	75	mg	null	null	Oral	YES	Chemotherapy	null	150	mg
TCGA-06-6388	TCGA-06-6388-D23052	119	119	null	null	null	null	null	Bevacizumab	null	null	10	mg	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	886	mg
TCGA-06-6389	TCGA-06-6389-D23104	72	32	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	140	mg
TCGA-06-6389	TCGA-06-6389-D23105	null	58	null	null	null	null	null	Temozolomide	null	02	150	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	240	mg
TCGA-06-6390	TCGA-06-6390-D23109	68	22	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-6390	TCGA-06-6390-D23110	88	88	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-06-6695	TCGA-06-6695-D23058	56	11	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	140	mg
TCGA-06-6695	TCGA-06-6695-D23059	120	62	null	null	null	null	null	Temozolomide	null	02	150	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	280	mg
TCGA-06-6697	TCGA-06-6697-D23063	275	232	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	160	mg
TCGA-06-6697	TCGA-06-6697-D23064	304	273	null	null	null	null	null	Temozolomide	null	01	150	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	320	mg
TCGA-06-6697	TCGA-06-6697-D23065	334	304	null	null	null	null	null	Temozolomide	null	01	75	mg/day	null	null	Oral	NO	Chemotherapy	null	140	mg/day
TCGA-06-6697	TCGA-06-6697-D23066	null	359	null	null	null	null	null	Bevacozimab	null	null	10	mg	null	null	Intravenous (IV)	YES	Targeted Molecular therapy	null	913	mg
TCGA-06-6698	TCGA-06-6698-D23070	null	null	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-06-6698	TCGA-06-6698-D23071	null	null	null	null	null	null	null	Temozolomide	null	null	null	null	ADJUVANT	null	Oral	YES	Chemotherapy	null	null	mg
TCGA-06-6699	TCGA-06-6699-D23075	null	30	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	null	mg
TCGA-06-6700	TCGA-06-6700-D23079	60	27	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg
TCGA-06-6700	TCGA-06-6700-D23080	null	91	null	null	null	null	null	Temozolomide	null	null	150	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	300	mg
TCGA-06-6700	TCGA-06-6700-D23081	77	22	null	null	null	null	null	Vandetanib	null	null	100	mg	ADJUVANT	null	Oral	NO	Targeted Molecular therapy	null	400	mg
TCGA-06-6701	TCGA-06-6701-D23085	63	20	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	140	mg
TCGA-08-0244	TCGA-08-0244-D23118	74	34	null	null	null	null	null	Temodor	null	null	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	null	null
TCGA-08-0244	TCGA-08-0244-D23119	484	34	null	null	null	null	null	Thalidomide	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	500	mg/day
TCGA-08-0245	TCGA-08-0245-D23123	843	560	null	null	null	null	null	Temodar	null	12	null	null	null	null	Oral	null	Chemotherapy	null	150	mg/m2
TCGA-08-0245	TCGA-08-0245-D23124	933	875	null	null	null	null	null	BCNU	null	01	null	null	null	null	Oral	null	Chemotherapy	null	150	mg/m2
TCGA-08-0245	TCGA-08-0245-D23125	1065	933	null	null	null	null	null	BCNU	null	3	null	null	null	null	Intravenous (IV)	null	Chemotherapy	null	150	mg/m2
TCGA-08-0245	TCGA-08-0245-D23126	933	878	null	null	null	null	null	null	null	null	null	null	null	null	null	null	Hormone Therapy	null	200	mg
TCGA-08-0246	TCGA-08-0246-D23132	92	35	null	null	null	null	null	Temodor	null	null	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	null	null
TCGA-08-0344	TCGA-08-0344-D23136	2850	2586	null	null	null	null	null	BCNU	null	07	null	null	null	null	Oral	NO	Chemotherapy	null	null	null
TCGA-08-0346	TCGA-08-0346-D23145	68	20	null	null	null	null	null	Hydroxyurea	null	1	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	300	mg
TCGA-08-0347	TCGA-08-0347-D23149	54	10	null	null	null	null	null	Hydroxurea	null	01	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	300	mg/m2
TCGA-08-0347	TCGA-08-0347-D23150	419	69	null	null	null	null	null	BCNU	null	06	null	null	null	null	Intravenous (IV)	null	Chemotherapy	null	400	mg
TCGA-08-0347	TCGA-08-0347-D23151	465	422	null	null	null	null	null	Procarbazine	null	01	null	null	null	null	Oral	null	Chemotherapy	null	100	mg/m2
TCGA-08-0347	TCGA-08-0347-D23152	605	486	null	null	null	null	null	Carboplatin	null	04	null	null	null	null	Intravenous (IV)	null	Chemotherapy	null	350	mg
TCGA-08-0348	TCGA-08-0348-D23158	203	27	null	null	null	null	null	Temodor	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-08-0348	TCGA-08-0348-D23159	287	214	null	null	null	null	null	VP-16	null	null	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-08-0348	TCGA-08-0348-D23160	135	27	null	null	null	null	null	Thalidomide	null	null	null	null	ADJUVANT	null	null	null	Targeted Molecular therapy	null	1000	mg/day
TCGA-08-0348	TCGA-08-0348-D23161	287	214	null	null	null	null	null	Tamoxifen	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	180	mg/day
TCGA-08-0349	TCGA-08-0349-D23166	92	37	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2/day
TCGA-08-0349	TCGA-08-0349-D23167	182	104	null	null	null	null	null	BCNU	null	02	null	null	null	null	Oral	null	Chemotherapy	null	480	mg
TCGA-08-0349	TCGA-08-0349-D23168	259	231	null	null	null	null	null	Fenretinide	null	01	null	null	null	null	Oral	null	Chemotherapy	null	2600	mg/day
TCGA-08-0349	TCGA-08-0349-D23169	92	37	null	null	null	null	null	Thalidomide	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	200	mg/day
TCGA-08-0350	TCGA-08-0350-D23173	637	455	null	null	null	null	null	Temodor	null	05	null	null	null	null	Oral	NO	Chemotherapy	null	null	null
TCGA-08-0350	TCGA-08-0350-D23174	837	678	null	null	null	null	null	Tarceva	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	450	mg/day
TCGA-08-0351	TCGA-08-0351-D23179	null	59	null	null	null	null	null	Temodor	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-08-0351	TCGA-08-0351-D23180	null	1580	null	null	null	null	null	Temodor	null	null	null	null	null	null	Oral	NO	Chemotherapy	null	null	null
TCGA-08-0351	TCGA-08-0351-D23181	580	59	null	null	null	null	null	Thalidomide	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	null	mg/day
TCGA-08-0351	TCGA-08-0351-D23182	null	1580	null	null	null	null	null	Thalidomide	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	200	mg
TCGA-08-0353	TCGA-08-0353-D23188	76	6	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-08-0353	TCGA-08-0353-D23189	174	121	null	null	null	null	null	Temodar	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2/day
TCGA-08-0354	TCGA-08-0354-D23194	320	261	null	null	null	null	null	Temador	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	200	mg/day
TCGA-08-0354	TCGA-08-0354-D23195	253	28	null	null	null	null	null	Poly LCLC	null	8	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	.8	mL
TCGA-08-0354	TCGA-08-0354-D23196	390	345	null	null	null	null	null	BCNU	null	2	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	380	mg
TCGA-08-0354	TCGA-08-0354-D23197	393	345	null	null	null	null	null	cis retinoic acid	null	1	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	180	mg
TCGA-08-0354	TCGA-08-0354-D23198	320	261	null	null	null	null	null	Tarceva	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	450	mg/day
TCGA-08-0355	TCGA-08-0355-D23202	68	25	null	null	null	null	null	Temodor	null	1	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	75	mg/m2
TCGA-08-0355	TCGA-08-0355-D23203	498	88	null	null	null	null	null	Temodor	null	14	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-08-0355	TCGA-08-0355-D23204	531	531	null	null	null	null	null	BCNU	null	1	null	null	null	null	Intravenous (IV)	null	Chemotherapy	null	210	mg
TCGA-08-0355	TCGA-08-0355-D23205	582	582	null	null	null	null	null	Carboplatin	null	1	null	null	null	null	Intravenous (IV)	null	Chemotherapy	null	590	mg
TCGA-08-0355	TCGA-08-0355-D23206	572	531	null	null	null	null	null	Thalomid	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	1000	mg/day
TCGA-08-0355	TCGA-08-0355-D23207	607	573	null	null	null	null	null	Tamoxifen	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	540	mg
TCGA-08-0355	TCGA-08-0355-D23208	671	640	null	null	null	null	null	Enzastaurin	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	null	null
TCGA-08-0356	TCGA-08-0356-D23212	82	42	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/day
TCGA-08-0356	TCGA-08-0356-D23213	447	92	null	null	null	null	null	Temodar	null	12	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg
TCGA-08-0357	TCGA-08-0357-D23217	860	736	null	null	null	null	null	CCNU	null	3	null	null	null	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-08-0357	TCGA-08-0357-D23218	136	93	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg
TCGA-08-0357	TCGA-08-0357-D23219	733	689	null	null	null	null	null	Hyrdroxyurea	null	1	null	null	null	null	Oral	NO	Chemotherapy	null	1000	mg/day
TCGA-08-0357	TCGA-08-0357-D23220	71	29	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg
TCGA-08-0357	TCGA-08-0357-D23221	985	875	null	null	null	null	null	VP-16	null	3	null	null	null	null	Oral	NO	Chemotherapy	null	100	mg
TCGA-08-0357	TCGA-08-0357-D23222	860	736	null	null	null	null	null	Interferon Alpha	null	null	null	null	null	null	null	NO	Immunotherapy	null	null	null
TCGA-08-0357	TCGA-08-0357-D23223	188	184	null	null	null	null	null	IL-13 Pseudomonas exotoxin	null	null	null	null	null	null	null	NO	Immunotherapy	null	36	mg
TCGA-08-0357	TCGA-08-0357-D23224	860	736	null	null	null	null	null	Rapamycin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	5	mg/day
TCGA-08-0357	TCGA-08-0357-D23225	136	93	null	null	null	null	null	Thalidomide	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	null	null
TCGA-08-0357	TCGA-08-0357-D23226	733	689	null	null	null	null	null	Gleevac	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	1000	mg/day
TCGA-08-0357	TCGA-08-0357-D23227	688	471	null	null	null	null	null	Irinotecan	null	null	null	null	null	null	null	YES	Targeted Molecular therapy	null	775	mg
TCGA-08-0357	TCGA-08-0357-D23228	1084	1007	null	null	null	null	null	Sorafenib	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	400	mg/day
TCGA-08-0357	TCGA-08-0357-D23229	1112	1097	null	null	null	null	null	Cytoxan	null	null	null	null	null	null	null	YES	Targeted Molecular therapy	null	100	mg/day
TCGA-08-0357	TCGA-08-0357-D23230	1084	1007	null	null	null	null	null	Tarveca	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	100	mg
TCGA-08-0357	TCGA-08-0357-D23231	688	471	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	475	mg
TCGA-08-0358	TCGA-08-0358-D23235	75	33	null	null	null	null	null	Temodor	null	01	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	150	mg/day
TCGA-08-0358	TCGA-08-0358-D23236	263	90	null	null	null	null	null	Temodor	null	06	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	200	mg/m2
TCGA-08-0358	TCGA-08-0358-D23237	547	490	null	null	null	null	null	CCNU	null	01	null	null	null	null	Oral	null	Chemotherapy	null	220	mg
TCGA-08-0358	TCGA-08-0358-D23238	292	287	null	null	null	null	null	IL-13 with Pseudomonas Exotoxin	null	null	null	null	null	null	null	null	Immunotherapy	null	36	mg
TCGA-08-0358	TCGA-08-0358-D23239	466	341	null	null	null	null	null	HSPPC-96 Vaccine	null	null	null	null	null	null	null	null	Immunotherapy	null	0.4	mg
TCGA-08-0358	TCGA-08-0358-D23240	75	33	null	null	null	null	null	Tarceva	null	null	null	null	ADJUVANT	null	null	null	Targeted Molecular therapy	null	150	mg/day
TCGA-08-0358	TCGA-08-0358-D23241	263	90	null	null	null	null	null	Tarceva	null	null	null	null	ADJUVANT	null	null	null	Targeted Molecular therapy	null	200	mg/day
TCGA-08-0360	TCGA-08-0360-D23247	134	130	null	null	null	null	null	IL-13 with Pseudomonas exotoxin	null	null	null	null	null	null	null	NO	Immunotherapy	null	36	mg
TCGA-08-0380	TCGA-08-0380-D23256	330	293	null	null	null	null	null	VP16	null	1	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-08-0380	TCGA-08-0380-D23257	193	161	null	null	null	null	null	BCNU	null	01	null	null	null	null	Intravenous (IV)	null	Chemotherapy	null	375	mg
TCGA-08-0380	TCGA-08-0380-D23258	274	216	null	null	null	null	null	Temodar	null	null	null	null	null	null	Oral	null	Chemotherapy	null	345	mg
TCGA-08-0380	TCGA-08-0380-D23259	330	275	null	null	null	null	null	null	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	null	null
TCGA-08-0380	TCGA-08-0380-D23260	516	467	null	null	null	null	null	Marimastat	null	null	null	null	ADJUVANT	null	null	YES	Targeted Molecular therapy	null	200	mg/day
TCGA-08-0386	TCGA-08-0386-D23266	76	29	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-08-0386	TCGA-08-0386-D23267	427	95	null	null	null	null	null	Temodar	null	11	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-08-0386	TCGA-08-0386-D23268	125	113	null	null	null	null	null	HSPPC-96 Vaccine	null	null	null	null	null	null	null	NO	Immunotherapy	null	0.4	mg
TCGA-08-0386	TCGA-08-0386-D23269	76	29	null	null	null	null	null	Tarceva	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	200	mg/day
TCGA-08-0386	TCGA-08-0386-D23270	106	94	null	null	null	null	null	Tarceva	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	200	mg/day
TCGA-08-0389	TCGA-08-0389-D23274	null	30	null	null	null	null	null	Temodor	null	null	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	null	null
TCGA-08-0389	TCGA-08-0389-D23275	null	30	null	null	null	null	null	EMD	null	null	null	null	ADJUVANT	null	null	null	Targeted Molecular therapy	null	null	null
TCGA-08-0390	TCGA-08-0390-D23279	69	28	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	150	mg/day
TCGA-08-0390	TCGA-08-0390-D23280	132	105	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	300	mg
TCGA-08-0390	TCGA-08-0390-D23281	69	28	null	null	null	null	null	Tarceva	null	null	null	null	ADJUVANT	null	Oral	null	Immunotherapy	null	100	mg
TCGA-08-0390	TCGA-08-0390-D23282	132	105	null	null	null	null	null	Tarceva	null	null	null	null	ADJUVANT	null	Oral	null	Immunotherapy	null	150	mg
TCGA-08-0510	TCGA-08-0510-D23289	89	34	null	null	null	null	null	Temodor	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	330	mg/day
TCGA-08-0510	TCGA-08-0510-D23290	63	40	null	null	null	null	null	Thalidomide	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	null	mg
TCGA-08-0511	TCGA-08-0511-D23294	null	null	null	null	null	null	null	CCNU	null	null	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	210	mg
TCGA-08-0517	TCGA-08-0517-D23308	1359	1095	null	null	null	null	null	Procarbazine/CCNU/Vincristine	null	06	null	null	null	null	Oral	NO	Chemotherapy	null	null	null
TCGA-08-0517	TCGA-08-0517-D23309	1754	null	null	null	null	null	null	Accutane	null	null	null	null	null	null	Oral	NO	Chemotherapy	null	160	mg/day
TCGA-08-0520	TCGA-08-0520-D23316	null	180	null	null	null	null	null	Temodor	null	null	null	null	null	null	Oral	null	Chemotherapy	null	200	mg/m2
TCGA-08-0521	TCGA-08-0521-D23321	63	27	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	140	mg
TCGA-08-0521	TCGA-08-0521-D23322	126	99	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	300	mg
TCGA-08-0522	TCGA-08-0522-D23326	65	22	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	140	mg
TCGA-08-0522	TCGA-08-0522-D23327	214	61	null	null	null	null	null	Temodar	null	4	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	280	mg
TCGA-08-0522	TCGA-08-0522-D23328	555	517	null	null	null	null	null	Carboplatin	null	1	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-08-0522	TCGA-08-0522-D23329	271	268	null	null	null	null	null	IL-13-PE38QQR Cytoxin	null	null	null	null	null	null	null	NO	Immunotherapy	null	1	mg
TCGA-08-0522	TCGA-08-0522-D23330	511	423	null	null	null	null	null	LY317615	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	null	null
TCGA-08-0524	TCGA-08-0524-D23336	296	194	null	null	null	null	null	Thalidomide	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	null	null
TCGA-08-0524	TCGA-08-0524-D23337	122	73	null	null	null	null	null	SCH63666	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	150	mg
TCGA-08-0524	TCGA-08-0524-D23338	188	137	null	null	null	null	null	Gleevec	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	350	mg
TCGA-08-0524	TCGA-08-0524-D23334	198	194	null	null	null	null	null	CCNU	null	1	null	null	null	null	Oral	null	Chemotherapy	null	170	mg
TCGA-08-0524	TCGA-08-0524-D23335	52	24	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	120	mg/day
TCGA-08-0525	TCGA-08-0525-D23342	39	6	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	75	mg/m2/day
TCGA-08-0525	TCGA-08-0525-D23343	341	37	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	null	null
TCGA-08-0525	TCGA-08-0525-D23344	402	370	null	null	null	null	null	OS1-774	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	null	null
TCGA-08-0529	TCGA-08-0529-D23348	84	41	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/day
TCGA-08-0529	TCGA-08-0529-D23349	328	106	null	null	null	null	null	Temodar	null	7	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg
TCGA-08-0529	TCGA-08-0529-D23350	353	349	null	null	null	null	null	IL-13 Pseudomonas exotoxin	null	null	null	null	null	null	null	NO	Immunotherapy	null	36	mg
TCGA-08-0531	TCGA-08-0531-D23354	69	27	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	135	mg
TCGA-08-0531	TCGA-08-0531-D23355	198	102	null	null	null	null	null	Temodar	null	4	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	300	mg
TCGA-12-0615	TCGA-12-0615-D23453	28	28	null	null	null	null	null	Gliadel wafers	null	1	null	null	ADJUVANT	null	Intratumoral	NO	Chemotherapy	null	8	{Wafer}
TCGA-12-0615	TCGA-12-0615-D23454	null	null	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-0615	TCGA-12-0615-D23455	171	101	null	null	null	null	null	Temodar	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0615	TCGA-12-0615-D23456	277	194	null	null	null	null	null	CPT-11	null	2	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	125	mg/m2
TCGA-12-0615	TCGA-12-0615-D23457	277	194	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	10	mg
TCGA-12-0615	TCGA-12-0615-D23458	383	277	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-0616	TCGA-12-0616-D23462	348	260	null	null	null	null	null	CPT-11	null	2	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	340	mg/m2
TCGA-12-0616	TCGA-12-0616-D23463	432	406	null	null	null	null	null	Hydroxyurea	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	1000	mg
TCGA-12-0616	TCGA-12-0616-D23464	74	29	null	null	null	null	null	Temozolamide	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-0616	TCGA-12-0616-D23465	259	105	null	null	null	null	null	Temozolamide	null	4	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0616	TCGA-12-0616-D23466	406	362	null	null	null	null	null	Temozolomide	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0616	TCGA-12-0616-D23467	348	260	null	null	null	null	null	Avastin	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-0616	TCGA-12-0616-D23468	432	406	null	null	null	null	null	Gleevac	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	700	mg
TCGA-12-0616	TCGA-12-0616-D23469	432	406	null	null	null	null	null	Rad001	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	2.5	mg
TCGA-12-0618	TCGA-12-0618-D23473	0	0	null	null	null	null	null	Gliadel wafers	null	01	null	null	ADJUVANT	null	Intratumoral	null	Chemotherapy	null	8	{Wafer}
TCGA-12-0618	TCGA-12-0618-D23474	64	8	null	null	null	null	null	Temodar	null	02	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	150	mg/m2
TCGA-12-0619	TCGA-12-0619-D23478	0	0	null	null	null	null	null	Gliadel Wafers	null	1	null	null	ADJUVANT	null	Intratumoral	NO	Chemotherapy	null	8	{Wafer}
TCGA-12-0619	TCGA-12-0619-D23479	84	21	null	null	null	null	null	Temozolamide	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0619	TCGA-12-0619-D23480	129	84	null	null	null	null	null	CCNU	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0619	TCGA-12-0619-D23481	203	163	null	null	null	null	null	CCNU	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	82.5	mg/m2
TCGA-12-0619	TCGA-12-0619-D23482	291	228	null	null	null	null	null	Temozolamide	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0619	TCGA-12-0619-D23483	350	291	null	null	null	null	null	VP-16	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0619	TCGA-12-0619-D23484	571	443	null	null	null	null	null	VP-16	null	4	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0620	TCGA-12-0620-D23488	68	21	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-0620	TCGA-12-0620-D23489	191	92	null	null	null	null	null	CCNU	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0654	TCGA-12-0654-D23493	216	44	null	null	null	null	null	MAb I-131	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	120	mCi
TCGA-12-0654	TCGA-12-0654-D23494	216	44	null	null	null	null	null	mu81c6	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	20	mg
TCGA-12-0656	TCGA-12-0656-D23498	203	134	null	null	null	null	null	CCNU	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0656	TCGA-12-0656-D23499	253	203	null	null	null	null	null	CCNU	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	55	mg/m2
TCGA-12-0656	TCGA-12-0656-D23500	443	301	null	null	null	null	null	VP-16	null	2	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	37.5	mg/m2
TCGA-12-0656	TCGA-12-0656-D23501	1758	1488	null	null	null	null	null	Temodar	null	6	null	null	null	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0656	TCGA-12-0656-D23502	1817	1758	null	null	null	null	null	CCNU	null	1	null	null	null	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0656	TCGA-12-0656-D23503	1873	1817	null	null	null	null	null	CCNU	null	1	null	null	null	null	Oral	NO	Chemotherapy	null	82.5	mg/m2
TCGA-12-0656	TCGA-12-0656-D23504	1899	1873	null	null	null	null	null	VP-16	null	01	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0656	TCGA-12-0656-D23505	22	22	null	null	null	null	null	MAb I-131	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	120	mCi
TCGA-12-0656	TCGA-12-0656-D23506	22	22	null	null	null	null	null	mu81c6	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	20	mg
TCGA-12-0662	TCGA-12-0662-D23512	220	119	null	null	null	null	null	CCNU	null	02	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	110	mg/m2
TCGA-12-0662	TCGA-12-0662-D23513	278	223	null	null	null	null	null	VP-16	null	02	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	100	mg/m2
TCGA-12-0662	TCGA-12-0662-D23514	417	340	null	null	null	null	null	CCNU	null	02	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	110	mg/m2
TCGA-12-0662	TCGA-12-0662-D23515	472	417	null	null	null	null	null	VP-16	null	2	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	100	mg/m2
TCGA-12-0662	TCGA-12-0662-D23516	603	599	null	null	null	null	null	Temodar	null	01	null	null	null	null	Oral	null	Chemotherapy	null	150	mg/m2
TCGA-12-0662	TCGA-12-0662-D23517	843	626	null	null	null	null	null	Temodar	null	07	null	null	null	null	Oral	null	Chemotherapy	null	200	mg/m2
TCGA-12-0662	TCGA-12-0662-D23518	875	875	null	null	null	null	null	Gliadel Wafers	null	01	null	null	null	null	Intratumoral	null	Chemotherapy	null	8	{Wafer}
TCGA-12-0662	TCGA-12-0662-D23519	1028	888	null	null	null	null	null	CPT-11	null	03	null	null	null	null	Intravenous (IV)	null	Chemotherapy	null	75	mg/m2
TCGA-12-0662	TCGA-12-0662-D23520	1070	1041	null	null	null	null	null	VP-16	null	01	null	null	null	null	Oral	null	Chemotherapy	null	50	mg/m2
TCGA-12-0662	TCGA-12-0662-D23521	1070	1041	null	null	null	null	null	Cytoxan	null	01	null	null	null	null	Oral	null	Chemotherapy	null	100	mg
TCGA-12-0662	TCGA-12-0662-D23522	1137	1133	null	null	null	null	null	Temodar	null	null	null	null	null	null	Oral	null	Chemotherapy	null	10	mg/m2
TCGA-12-0662	TCGA-12-0662-D23523	334	278	null	null	null	null	null	Tamoxiten	null	null	null	null	ADJUVANT	null	null	null	Hormone Therapy	null	100	mg
TCGA-12-0662	TCGA-12-0662-D23524	599	472	null	null	null	null	null	Tamoxifen	null	null	null	null	ADJUVANT	null	null	null	Hormone Therapy	null	200	mg
TCGA-12-0662	TCGA-12-0662-D23525	1161	1113	null	null	null	null	null	Celbrex	null	null	null	null	null	null	Oral	null	Immunotherapy	null	400	mg
TCGA-12-0662	TCGA-12-0662-D23526	1090	1073	null	null	null	null	null	Thalidomide	null	null	null	null	null	null	null	null	Immunotherapy	null	400	mg
TCGA-12-0662	TCGA-12-0662-D23527	1135	1133	null	null	null	null	null	06GB	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	120	mg/m2
TCGA-12-0662	TCGA-12-0662-D23528	1135	1133	null	null	null	null	null	06GB	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	30	mg/m2
TCGA-12-0670	TCGA-12-0670-D23542	601	578	null	null	null	null	null	Tamoxifen	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	200	mg
TCGA-12-0670	TCGA-12-0670-D23543	722	601	null	null	null	null	null	Tamoxifen	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	200	mg
TCGA-12-0670	TCGA-12-0670-D23544	378	327	null	null	null	null	null	Celebrex	null	null	null	null	ADJUVANT	null	Oral	NO	Immunotherapy	null	125	mg/m2
TCGA-12-0670	TCGA-12-0670-D23545	448	407	null	null	null	null	null	Celebrex	null	null	null	null	ADJUVANT	null	Oral	NO	Immunotherapy	null	125	mg/m2
TCGA-12-0670	TCGA-12-0670-D23546	516	448	null	null	null	null	null	Celebrex	null	null	null	null	ADJUVANT	null	Oral	NO	Immunotherapy	null	125	mg/m2
TCGA-12-0670	TCGA-12-0670-D23547	576	516	null	null	null	null	null	Celebrex	null	null	null	null	ADJUVANT	null	Oral	NO	Immunotherapy	null	125	mg/m2
TCGA-12-0670	TCGA-12-0670-D23548	601	578	null	null	null	null	null	Celebrex	null	null	null	null	ADJUVANT	null	Oral	NO	Immunotherapy	null	125	mg/m2
TCGA-12-0670	TCGA-12-0670-D23549	722	601	null	null	null	null	null	Celebrex	null	null	null	null	ADJUVANT	null	Oral	NO	Immunotherapy	null	125	mg/m2
TCGA-12-0670	TCGA-12-0670-D23550	770	722	null	null	null	null	null	Celebrex	null	null	null	null	ADJUVANT	null	Oral	NO	Immunotherapy	null	125	mg/m2
TCGA-12-0670	TCGA-12-0670-D23551	77	43	null	null	null	null	null	MAB I131	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	80	mCi
TCGA-12-0670	TCGA-12-0670-D23552	77	43	null	null	null	null	null	ch81c6	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	10	mg
TCGA-12-0670	TCGA-12-0670-D23532	183	148	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0670	TCGA-12-0670-D23533	203	183	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0670	TCGA-12-0670-D23534	288	211	null	null	null	null	null	CCNU	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0670	TCGA-12-0670-D23535	378	329	null	null	null	null	null	CPT-11	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	125	mg/m2
TCGA-12-0670	TCGA-12-0670-D23536	448	407	null	null	null	null	null	CPT-11	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	125	mg/m2
TCGA-12-0670	TCGA-12-0670-D23537	516	448	null	null	null	null	null	Temozolomide	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0670	TCGA-12-0670-D23538	576	516	null	null	null	null	null	CCNU	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0670	TCGA-12-0670-D23539	601	578	null	null	null	null	null	CCNU	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0670	TCGA-12-0670-D23540	516	448	null	null	null	null	null	Tamoxifen	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	200	mg
TCGA-12-0670	TCGA-12-0670-D23541	576	516	null	null	null	null	null	Tamoxifen	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	200	mg
TCGA-12-0688	TCGA-12-0688-D23556	179	96	null	null	null	null	null	CCNU	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0688	TCGA-12-0688-D23557	238	215	null	null	null	null	null	VP-16	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	37.5	mg/m2
TCGA-12-0688	TCGA-12-0688-D23558	353	238	null	null	null	null	null	VP-16	null	03	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	25	mg/m2
TCGA-12-0688	TCGA-12-0688-D23559	597	501	null	null	null	null	null	Temozolamide	null	3	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0688	TCGA-12-0688-D23560	649	605	null	null	null	null	null	CPT-11	null	1	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	340	mg/m2
TCGA-12-0688	TCGA-12-0688-D23561	734	649	null	null	null	null	null	VP-16	null	3	null	null	null	null	Oral	NO	Chemotherapy	null	25	mg
TCGA-12-0688	TCGA-12-0688-D23562	353	238	null	null	null	null	null	Tamoxiten	null	null	null	null	ADJUVANT	null	null	null	Hormone Therapy	null	100	mg
TCGA-12-0691	TCGA-12-0691-D23566	158	116	null	null	null	null	null	Temodar	null	1	null	null	null	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0691	TCGA-12-0691-D23567	185	158	null	null	null	null	null	Temodar	null	1	null	null	null	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0692	TCGA-12-0692-D23571	45	14	null	null	null	null	null	Temozolomide	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0703	TCGA-12-0703-D23574	301	214	null	null	null	null	null	CPT-11	null	3	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	125	mg/m2
TCGA-12-0703	TCGA-12-0703-D23575	529	321	null	null	null	null	null	Carmustine	null	5	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	100	mg
TCGA-12-0703	TCGA-12-0703-D23576	529	321	null	null	null	null	null	Topecan	null	05	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	0.75	mg/m2
TCGA-12-0703	TCGA-12-0703-D23577	125	13	null	null	null	null	null	MAb I-131	null	null	null	null	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	120	mCi
TCGA-12-0703	TCGA-12-0703-D23578	125	13	null	null	null	null	null	mu81c6	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	20	mg
TCGA-12-0769	TCGA-12-0769-D23583	78	33	null	null	null	null	null	Temodar	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0769	TCGA-12-0769-D23584	192	91	null	null	null	null	null	CCNU	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0769	TCGA-12-0769-D23585	250	192	null	null	null	null	null	Temodar	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0769	TCGA-12-0769-D23586	341	250	null	null	null	null	null	cpt-11	null	2	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-12-0772	TCGA-12-0772-D23590	120	79	null	null	null	null	null	Temozolamide	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0772	TCGA-12-0772-D23591	489	120	null	null	null	null	null	VP-16	null	12	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0772	TCGA-12-0772-D23592	1468	1307	null	null	null	null	null	Cytoxan	null	05	null	null	null	null	Oral	null	Chemotherapy	null	100	mg
TCGA-12-0772	TCGA-12-0772-D23593	951	670	null	null	null	null	null	CPT-11	null	6	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	125	mg/m2
TCGA-12-0772	TCGA-12-0772-D23594	1112	951	null	null	null	null	null	CCNU	null	3	null	null	null	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0772	TCGA-12-0772-D23595	1174	1112	null	null	null	null	null	Temozolamide	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0772	TCGA-12-0772-D23596	1265	1224	null	null	null	null	null	CCNU	null	1	null	null	null	null	Oral	NO	Chemotherapy	null	82.5	mg/m2
TCGA-12-0772	TCGA-12-0772-D23597	1616	1529	null	null	null	null	null	VP-16	null	03	null	null	null	null	Oral	null	Chemotherapy	null	50	mg/m2
TCGA-12-0772	TCGA-12-0772-D23598	670	621	null	null	null	null	null	ARIAD AP23573	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	12.5	mg
TCGA-12-0772	TCGA-12-0772-D23599	1526	1468	null	null	null	null	null	Tarceva	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	150	mg/kg
TCGA-12-0772	TCGA-12-0772-D23600	1526	1468	null	null	null	null	null	Sirolimus	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	10	mg
TCGA-12-0772	TCGA-12-0772-D23601	1526	1468	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	10	mg
TCGA-12-0772	TCGA-12-0772-D23602	1616	1529	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-0772	TCGA-12-0772-D23603	1468	1307	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-0773	TCGA-12-0773-D23608	1274	1141	null	null	null	null	null	Temozolomide	null	2	null	null	null	null	Oral	null	Chemotherapy	null	50	mg/m2
TCGA-12-0773	TCGA-12-0773-D23609	245	150	null	null	null	null	null	Temozolamide	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0773	TCGA-12-0773-D23610	326	235	null	null	null	null	null	CCNU	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	82.5	mg/m2
TCGA-12-0773	TCGA-12-0773-D23611	431	326	null	null	null	null	null	CPT-11	null	2	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	125	mg/m2
TCGA-12-0773	TCGA-12-0773-D23612	516	431	null	null	null	null	null	Temozolamide	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0773	TCGA-12-0773-D23613	607	516	null	null	null	null	null	CCNU	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	82.5	mg/m2
TCGA-12-0773	TCGA-12-0773-D23614	875	773	null	null	null	null	null	Temozolamide	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0773	TCGA-12-0773-D23615	1015	892	null	null	null	null	null	CCNU	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	82.5	mg/m2
TCGA-12-0773	TCGA-12-0773-D23616	1036	1015	null	null	null	null	null	VP-16	null	1	null	null	null	null	Oral	NO	Chemotherapy	null	37.5	mg/m2
TCGA-12-0773	TCGA-12-0773-D23617	1141	1062	null	null	null	null	null	Temozolomide	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0773	TCGA-12-0773-D23618	1311	1274	null	null	null	null	null	Temozolamide	null	2	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0773	TCGA-12-0773-D23619	725	607	null	null	null	null	null	Tamoxifen	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	100	mg
TCGA-12-0773	TCGA-12-0773-D23620	56	55	null	null	null	null	null	MAb I-131	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	61	mCi
TCGA-12-0773	TCGA-12-0773-D23621	56	55	null	null	null	null	null	MU81C6	null	null	null	null	ADJUVANT	null	null	null	Targeted Molecular therapy	null	10	mg
TCGA-12-0773	TCGA-12-0773-D23622	1274	1141	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-0773	TCGA-12-0773-D23623	56	55	null	null	null	null	null	mu81c6	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	10	mg
TCGA-12-0775	TCGA-12-0775-D23627	94	37	null	null	null	null	null	Temodar	null	02	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	160	mg/m2
TCGA-12-0775	TCGA-12-0775-D23628	158	117	null	null	null	null	null	CCNU	null	01	null	null	null	null	Oral	null	Chemotherapy	null	90	mg/m2
TCGA-12-0776	TCGA-12-0776-D23632	74	33	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-0776	TCGA-12-0776-D23633	127	82	null	null	null	null	null	CCNU	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0776	TCGA-12-0776-D23634	275	140	null	null	null	null	null	CPT-11	null	02	null	null	null	null	Intravenous (IV)	null	Chemotherapy	null	340	mg/m2
TCGA-12-0776	TCGA-12-0776-D23635	275	140	null	null	null	null	null	Avastin	null	null	null	null	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-0778	TCGA-12-0778-D23645	329	249	null	null	null	null	null	Avastin	null	null	null	null	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-0778	TCGA-12-0778-D23646	385	355	null	null	null	null	null	Tarceva	null	null	null	null	null	null	Oral	null	Targeted Molecular therapy	null	200	mg
TCGA-12-0778	TCGA-12-0778-D23647	385	355	null	null	null	null	null	Rapamycin	null	null	null	null	null	null	Oral	NO	Targeted Molecular therapy	null	15	mg/day
TCGA-12-0778	TCGA-12-0778-D23648	385	355	null	null	null	null	null	Rapamcyin	null	null	null	null	null	null	Oral	NO	Targeted Molecular therapy	null	150	mg
TCGA-12-0778	TCGA-12-0778-D23639	67	22	null	null	null	null	null	Temozolamide	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-0778	TCGA-12-0778-D23640	146	88	null	null	null	null	null	Temozolamide	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0778	TCGA-12-0778-D23641	231	146	null	null	null	null	null	CCNU	null	2	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg
TCGA-12-0778	TCGA-12-0778-D23642	352	329	null	null	null	null	null	Temozolomide	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0778	TCGA-12-0778-D23643	352	329	null	null	null	null	null	VP-16	null	01	null	null	null	null	Oral	null	Chemotherapy	null	50	mg/m2
TCGA-12-0778	TCGA-12-0778-D23644	329	249	null	null	null	null	null	VP-16	null	03	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0780	TCGA-12-0780-D23655	77	21	null	null	null	null	null	Temodar	null	1	null	null	null	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-0780	TCGA-12-0780-D23656	350	101	null	null	null	null	null	CPT-11	null	6	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	125	mg/m2
TCGA-12-0780	TCGA-12-0780-D23657	388	360	null	null	null	null	null	VP-16	null	1	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	37.5	mg/m2
TCGA-12-0780	TCGA-12-0780-D23658	350	111	null	null	null	null	null	Avastin	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-0780	TCGA-12-0780-D23659	388	360	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-0780	TCGA-12-0780-D23660	434	393	null	null	null	null	null	Tarceva	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	5	mg
TCGA-12-0780	TCGA-12-0780-D23661	434	393	null	null	null	null	null	Rapamycin	null	null	null	null	null	null	null	null	Targeted Molecular therapy	null	150	mg
TCGA-12-0818	TCGA-12-0818-D23665	135	75	null	null	null	null	null	VP-16	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0818	TCGA-12-0818-D23666	1642	135	null	null	null	null	null	CCNU	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0818	TCGA-12-0818-D23667	254	212	null	null	null	null	null	VP-16	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0818	TCGA-12-0818-D23668	295	254	null	null	null	null	null	CCNU	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0818	TCGA-12-0818-D23669	47	26	null	null	null	null	null	MAB I-131	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	80	mCi
TCGA-12-0818	TCGA-12-0818-D23670	47	26	null	null	null	null	null	81c6	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	10	mg
TCGA-12-0819	TCGA-12-0819-D23674	375	258	null	null	null	null	null	BCNU	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0819	TCGA-12-0819-D23675	441	375	null	null	null	null	null	BCNU	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0819	TCGA-12-0819-D23676	494	441	null	null	null	null	null	Topotecan	null	01	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	2.6	mg/m2
TCGA-12-0819	TCGA-12-0819-D23677	624	504	null	null	null	null	null	Procarbazine	null	04	null	null	null	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0819	TCGA-12-0819-D23678	1102	989	null	null	null	null	null	Carboplatin	null	04	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	600	mg
TCGA-12-0819	TCGA-12-0819-D23679	179	5	null	null	null	null	null	MAB I 131	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	60	mCi
TCGA-12-0819	TCGA-12-0819-D23680	179	5	null	null	null	null	null	mu81c6	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	9.9	mg
TCGA-12-0820	TCGA-12-0820-D23684	272	216	null	null	null	null	null	Temozolomide	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0820	TCGA-12-0820-D23685	341	300	null	null	null	null	null	BCNU	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	13.5	mg/m2
TCGA-12-0820	TCGA-12-0820-D23686	363	342	null	null	null	null	null	CPT-11	null	01	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	300	mg/m2
TCGA-12-0820	TCGA-12-0820-D23687	433	363	null	null	null	null	null	CPT-11	null	01	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	350	mg/m2
TCGA-12-0820	TCGA-12-0820-D23688	502	433	null	null	null	null	null	CPT-11	null	01	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	400	mg/m2
TCGA-12-0820	TCGA-12-0820-D23689	543	502	null	null	null	null	null	VP-16	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	62.5	mg/m2
TCGA-12-0820	TCGA-12-0820-D23690	543	502	null	null	null	null	null	Tamoxifen	null	null	null	null	null	null	Oral	NO	Hormone Therapy	null	200	mg
TCGA-12-0820	TCGA-12-0820-D23691	0	-1	null	null	null	null	null	06-BG	null	null	null	null	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	100	mg/m2
TCGA-12-0820	TCGA-12-0820-D23692	341	300	null	null	null	null	null	06-BG	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	100	mg/m2
TCGA-12-0821	TCGA-12-0821-D23696	165	123	null	null	null	null	null	CCNU	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0821	TCGA-12-0821-D23697	259	203	null	null	null	null	null	VP-16	null	02	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0821	TCGA-12-0821-D23698	296	271	null	null	null	null	null	CPT-11	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	190	mg/m2
TCGA-12-0822	TCGA-12-0822-D23702	174	125	null	null	null	null	null	CPT-11	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0822	TCGA-12-0822-D23703	174	125	null	null	null	null	null	BCNU	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	40	mg/m2
TCGA-12-0822	TCGA-12-0822-D23704	280	189	null	null	null	null	null	BCNU	null	02	null	null	null	null	Oral	NO	Chemotherapy	null	100	mg/m2
TCGA-12-0822	TCGA-12-0822-D23705	582	280	null	null	null	null	null	Temozolomide	null	10	null	null	null	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0822	TCGA-12-0822-D23706	623	587	null	null	null	null	null	VP-16	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0822	TCGA-12-0822-D23707	280	189	null	null	null	null	null	O6BG	null	null	null	null	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	40	mg/m2
TCGA-12-0822	TCGA-12-0822-D23708	624	624	null	null	null	null	null	SCH66336	null	null	null	null	null	null	Oral	NO	Targeted Molecular therapy	null	150	mg
TCGA-12-0822	TCGA-12-0822-D23709	651	624	null	null	null	null	null	SCH6636	null	null	null	null	null	null	Oral	NO	Targeted Molecular therapy	null	300	mg
TCGA-12-0827	TCGA-12-0827-D23715	181	137	null	null	null	null	null	CCNU	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-0827	TCGA-12-0827-D23716	258	181	null	null	null	null	null	CCNU	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	82.5	mg/m2
TCGA-12-0827	TCGA-12-0827-D23717	350	258	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-12-0827	TCGA-12-0827-D23718	390	350	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0827	TCGA-12-0827-D23719	434	390	null	null	null	null	null	CPT-11	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	410	mg/m2
TCGA-12-0827	TCGA-12-0827-D23720	615	466	null	null	null	null	null	Temozolomide	null	04	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0827	TCGA-12-0827-D23721	746	615	null	null	null	null	null	Tamoxifen	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	160	mg
TCGA-12-0827	TCGA-12-0827-D23722	76	34	null	null	null	null	null	MABI131	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	120	mCi
TCGA-12-0827	TCGA-12-0827-D23723	76	34	null	null	null	null	null	81C6	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	20	mg
TCGA-12-0828	TCGA-12-0828-D23727	151	28	null	null	null	null	null	Temozolomide	null	04	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0829	TCGA-12-0829-D23731	64	16	null	null	null	null	null	Temador	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-0829	TCGA-12-0829-D23732	473	95	null	null	null	null	null	Temador	null	06	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-0829	TCGA-12-0829-D23733	571	474	null	null	null	null	null	Temador	null	04	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-0829	TCGA-12-0829-D23734	599	572	null	null	null	null	null	CPT-11	null	01	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	125	mg/m2
TCGA-12-0829	TCGA-12-0829-D23735	473	115	null	null	null	null	null	ATTAC	null	null	null	null	ADJUVANT	null	null	NO	Immunotherapy	null	1	mL
TCGA-12-0829	TCGA-12-0829-D23736	571	474	null	null	null	null	null	Avastin	null	null	null	null	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-0829	TCGA-12-0829-D23737	599	572	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-1088	TCGA-12-1088-D23359	3820	3779	null	null	null	null	null	CCNU	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	82.5	mg/m2
TCGA-12-1088	TCGA-12-1088-D23360	3779	3735	null	null	null	null	null	CCNU	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-1089	TCGA-12-1089-D23364	147	105	null	null	null	null	null	CCNU	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	110	mg/m2
TCGA-12-1090	TCGA-12-1090-D23368	45	45	null	null	null	null	null	Gliadel Waters	null	01	null	null	ADJUVANT	null	Intratumoral	null	Chemotherapy	null	8	{Wafer}
TCGA-12-1090	TCGA-12-1090-D23369	190	125	null	null	null	null	null	Thalidomide	null	02	null	null	null	null	Oral	null	Chemotherapy	null	800	mg
TCGA-12-1090	TCGA-12-1090-D23370	190	125	null	null	null	null	null	Cyclophosphamide	null	02	null	null	null	null	Oral	null	Chemotherapy	null	100	mg
TCGA-12-1091	TCGA-12-1091-D23374	169	143	null	null	null	null	null	Temodor	null	01	null	null	null	null	Oral	null	Chemotherapy	null	200	mg/m2
TCGA-12-1091	TCGA-12-1091-D23375	206	179	null	null	null	null	null	Temodor	null	1	null	null	null	null	Oral	null	Chemotherapy	null	150	mg/m2
TCGA-12-1091	TCGA-12-1091-D23376	287	229	null	null	null	null	null	CCNG	null	1	null	null	null	null	Oral	null	Chemotherapy	null	90	mg/m2
TCGA-12-1091	TCGA-12-1091-D23377	330	288	null	null	null	null	null	CCNG	null	1	null	null	null	null	Oral	null	Chemotherapy	null	80	mg/m2
TCGA-12-1091	TCGA-12-1091-D23378	358	331	null	null	null	null	null	Temodor	null	1	null	null	null	null	Oral	null	Chemotherapy	null	200	mg/m2
TCGA-12-1091	TCGA-12-1091-D23379	453	358	null	null	null	null	null	VP-16	null	2	null	null	null	null	Oral	null	Chemotherapy	null	100	mg/m2
TCGA-12-1091	TCGA-12-1091-D23380	484	453	null	null	null	null	null	Temodor	null	01	null	null	null	null	Oral	null	Chemotherapy	null	150	mg/m2
TCGA-12-1091	TCGA-12-1091-D23381	521	484	null	null	null	null	null	Temodor	null	1	null	null	null	null	Oral	null	Chemotherapy	null	125	mg/m2
TCGA-12-1091	TCGA-12-1091-D23382	691	521	null	null	null	null	null	Temodor	null	3	null	null	null	null	Oral	null	Chemotherapy	null	300	mg/m2
TCGA-12-1091	TCGA-12-1091-D23383	926	819	null	null	null	null	null	VP-16	null	2	null	null	null	null	Oral	null	Chemotherapy	null	100	mg/m2
TCGA-12-1091	TCGA-12-1091-D23384	453	358	null	null	null	null	null	Tamoxifen	null	null	null	null	null	null	Oral	null	Hormone Therapy	null	160	mg
TCGA-12-1091	TCGA-12-1091-D23385	484	453	null	null	null	null	null	Tamoxifen	null	null	null	null	null	null	Oral	null	Hormone Therapy	null	160	mg
TCGA-12-1091	TCGA-12-1091-D23386	521	484	null	null	null	null	null	Tamoxifen	null	null	null	null	null	null	Oral	null	Hormone Therapy	null	160	mg
TCGA-12-1091	TCGA-12-1091-D23387	691	521	null	null	null	null	null	Tamoxiten	null	null	null	null	null	null	Oral	null	Hormone Therapy	null	120	mg
TCGA-12-1092	TCGA-12-1092-D23391	96	46	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-1092	TCGA-12-1092-D23392	204	119	null	null	null	null	null	Temodar	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-1092	TCGA-12-1092-D23393	232	205	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-1092	TCGA-12-1092-D23394	367	232	null	null	null	null	null	Temodar	null	04	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-1092	TCGA-12-1092-D23395	460	368	null	null	null	null	null	CPT 11	null	02	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	125	mg/m2
TCGA-12-1092	TCGA-12-1092-D23396	637	551	null	null	null	null	null	Temodar	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-1092	TCGA-12-1092-D23397	204	119	null	null	null	null	null	Avastin	null	null	null	null	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-1092	TCGA-12-1092-D23398	551	460	null	null	null	null	null	Tarceva	null	null	null	null	ADJUVANT	null	Oral	NO	Targeted Molecular therapy	null	150	mg
TCGA-12-1092	TCGA-12-1092-D23399	551	460	null	null	null	null	null	Rapamycin	null	null	null	null	ADJUVANT	null	Oral	NO	Targeted Molecular therapy	null	5	mg
TCGA-12-1093	TCGA-12-1093-D23403	79	38	null	null	null	null	null	Temodor	null	1	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	75	mg/m2
TCGA-12-1093	TCGA-12-1093-D23404	317	105	null	null	null	null	null	Temodor	null	5	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	1000	mg/m2
TCGA-12-1093	TCGA-12-1093-D23405	364	339	null	null	null	null	null	Temozolamide	null	1	null	null	null	null	Oral	null	Chemotherapy	null	50	mg/m2
TCGA-12-1093	TCGA-12-1093-D23406	364	339	null	null	null	null	null	Panzem	null	1	null	null	null	null	Oral	null	Chemotherapy	null	6000	mg
TCGA-12-1093	TCGA-12-1093-D23407	317	126	null	null	null	null	null	ATTAC	null	null	null	null	ADJUVANT	null	Oral	null	Immunotherapy	null	1	mL
TCGA-12-1094	TCGA-12-1094-D23411	67	18	null	null	null	null	null	Temodor	null	01	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	75	mg/m2
TCGA-12-1094	TCGA-12-1094-D23412	213	141	null	null	null	null	null	Temodor	null	3	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	600	mg/m2
TCGA-12-1094	TCGA-12-1094-D23413	269	231	null	null	null	null	null	CCNG	null	null	null	null	null	null	Oral	NO	Chemotherapy	null	125	mg/m2
TCGA-12-1094	TCGA-12-1094-D23414	336	286	null	null	null	null	null	Temodor	null	02	null	null	null	null	Oral	NO	Chemotherapy	null	100	mg/m2
TCGA-12-1094	TCGA-12-1094-D23415	215	104	null	null	null	null	null	ACT PEP3 KLH	null	null	null	null	ADJUVANT	null	Oral	NO	Immunotherapy	null	1	null
TCGA-12-1094	TCGA-12-1094-D23416	336	286	null	null	null	null	null	Avastin	null	null	null	null	null	null	Oral	NO	Targeted Molecular therapy	null	10	mg/m2
TCGA-12-1095	TCGA-12-1095-D23420	82	34	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-1095	TCGA-12-1095-D23421	286	112	null	null	null	null	null	CPT 11	null	04	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	340	mg/m2
TCGA-12-1095	TCGA-12-1095-D23422	412	404	null	null	null	null	null	VP 16	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	37.5	mg/m2
TCGA-12-1095	TCGA-12-1095-D23423	370	291	null	null	null	null	null	Avastin	null	null	null	null	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	10	mg/m2
TCGA-12-1095	TCGA-12-1095-D23424	412	404	null	null	null	null	null	Avastin	null	null	null	null	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	10	mg/m2
TCGA-12-1095	TCGA-12-1095-D23425	286	95	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	10	mg/m2
TCGA-12-1096	TCGA-12-1096-D23429	101	63	null	null	null	null	null	Temodor	null	1	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	75	mg/m2
TCGA-12-1096	TCGA-12-1096-D23430	201	130	null	null	null	null	null	Temodor	null	2	null	null	null	null	Oral	YES	Chemotherapy	null	300	mg/m2
TCGA-12-1096	TCGA-12-1096-D23431	277	202	null	null	null	null	null	CPT-11	null	2	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	250	mg/m2
TCGA-12-1096	TCGA-12-1096-D23432	277	202	null	null	null	null	null	Avastin	null	null	null	null	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	null	mg/m2
TCGA-12-1097	TCGA-12-1097-D23437	166	110	null	null	null	null	null	Temodar	null	02	null	null	null	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-12-1097	TCGA-12-1097-D23438	385	351	null	null	null	null	null	Temodar	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-1097	TCGA-12-1097-D23439	385	351	null	null	null	null	null	VP 16	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	50	mg/m2
TCGA-12-1097	TCGA-12-1097-D23440	343	177	null	null	null	null	null	AMG 102	null	null	null	null	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-12-1097	TCGA-12-1097-D23436	96	49	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-1098	TCGA-12-1098-D23444	74	35	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-1099	TCGA-12-1099-D23448	100	61	null	null	null	null	null	Temodor	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-12-1099	TCGA-12-1099-D23449	103	62	null	null	null	null	null	Avastin	null	null	null	null	null	null	Oral	NO	Targeted Molecular therapy	null	10	mg/m2
TCGA-12-1597	TCGA-12-1597-D23741	0	0	null	null	null	null	null	Gliadel Wafer	null	01	8	{Wafer}	ADJUVANT	null	Intratumoral	NO	Chemotherapy	null	8	{Wafer}
TCGA-12-1597	TCGA-12-1597-D23742	88	64	null	null	null	null	null	Temozolomide	null	01	150	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	1550	mg
TCGA-12-1597	TCGA-12-1597-D23743	545	123	null	null	null	null	null	CCNU	null	01	110	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	220	mg
TCGA-12-1597	TCGA-12-1597-D23744	308	181	null	null	null	null	null	CPT 11	null	03	125	mg	null	null	Intravenous (IV)	NO	Chemotherapy	null	2880	mg
TCGA-12-1597	TCGA-12-1597-D23745	348	313	null	null	null	null	null	Temozolomide	null	05	200	mg	null	null	Oral	NO	Chemotherapy	null	1950	mg
TCGA-12-1597	TCGA-12-1597-D23746	427	355	null	null	null	null	null	Temozolomide	null	02	150	mg	null	null	Oral	NO	Chemotherapy	null	1500	mg
TCGA-12-1598	TCGA-12-1598-D23750	82	33	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5000	mg
TCGA-12-1598	TCGA-12-1598-D23751	287	160	null	null	null	null	null	Temodar	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	4500	mg
TCGA-12-1599	TCGA-12-1599-D23755	59	24	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-12-1599	TCGA-12-1599-D23756	492	461	null	null	null	null	null	Hydroxyurea	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	30000	mg
TCGA-12-1599	TCGA-12-1599-D23757	391	160	null	null	null	null	null	Hydroxyurea	null	07	null	null	null	null	Oral	NO	Chemotherapy	null	66750	mg
TCGA-12-1599	TCGA-12-1599-D23758	671	621	null	null	null	null	null	CPT 11	null	01	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	1600	mg
TCGA-12-1599	TCGA-12-1599-D23759	727	675	null	null	null	null	null	Cytoxan	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	5300	mg
TCGA-12-1599	TCGA-12-1599-D23760	127	96	null	null	null	null	null	Gleevac	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	30000	mg
TCGA-12-1599	TCGA-12-1599-D23761	391	160	null	null	null	null	null	Gleevac	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	90400	mg
TCGA-12-1599	TCGA-12-1599-D23762	433	406	null	null	null	null	null	Erlotinib	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	14000	mg
TCGA-12-1599	TCGA-12-1599-D23763	433	406	null	null	null	null	null	Sirolimus	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	280	mg
TCGA-12-1599	TCGA-12-1599-D23764	602	438	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	5520	mg
TCGA-12-1599	TCGA-12-1599-D23765	671	621	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	1840	mg
TCGA-12-1599	TCGA-12-1599-D23766	727	675	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	1760	mg
TCGA-12-1599	TCGA-12-1599-D23767	602	438	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	5520	mg
TCGA-12-1600	TCGA-12-1600-D23771	84	43	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-12-1600	TCGA-12-1600-D23772	217	105	null	null	null	null	null	Temodar	null	04	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	12000	mg
TCGA-12-1602	TCGA-12-1602-D23776	56	17	null	null	null	null	null	Temodor	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	6000	mg
TCGA-12-1602	TCGA-12-1602-D23777	139	85	null	null	null	null	null	Temodor	null	02	null	null	null	null	Oral	NO	Chemotherapy	null	8400	mg
TCGA-12-3644	TCGA-12-3644-D23783	179	134	null	null	null	null	null	CCNU	null	1	110	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	190	mg
TCGA-12-3644	TCGA-12-3644-D23784	488	179	null	null	null	null	null	Temodar	null	10	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	17000	mg
TCGA-12-3644	TCGA-12-3644-D23785	891	861	null	null	null	null	null	Temodar	null	1	200	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	1700	mg
TCGA-12-3644	TCGA-12-3644-D23786	1142	1030	null	null	null	null	null	Temodar	null	07	50	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	10080	mg
TCGA-12-3644	TCGA-12-3644-D23787	1180	1142	null	null	null	null	null	Temodar	null	1	75	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	3500	mg
TCGA-12-3644	TCGA-12-3644-D23788	1583	1194	null	null	null	null	null	CPT 11	null	09	125	mg	RECURRENCE	null	Intravenous (IV)	NO	Chemotherapy	null	5400	mg
TCGA-12-3644	TCGA-12-3644-D23789	1611	1583	null	null	null	null	null	Hydroxyuerea	null	1	500	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	14000	mg
TCGA-12-3644	TCGA-12-3644-D23790	1639	1611	null	null	null	null	null	Hydroxyurea	null	1	500	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	14000	mg
TCGA-12-3644	TCGA-12-3644-D23791	1722	1639	null	null	null	null	null	CPT 11	null	3	125	mg	RECURRENCE	null	Intravenous (IV)	NO	Chemotherapy	null	1200	mg
TCGA-12-3644	TCGA-12-3644-D23792	1722	1639	null	null	null	null	null	Temodar	null	03	150	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	1825	mg
TCGA-12-3644	TCGA-12-3644-D23793	1030	891	null	null	null	null	null	Tarceva	null	null	150	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	21000	mg
TCGA-12-3644	TCGA-12-3644-D23794	1030	891	null	null	null	null	null	Rapamycin	null	null	5	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	700	mg
TCGA-12-3644	TCGA-12-3644-D23795	1154	1150	null	null	null	null	null	06BG	null	null	120	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	600	mg
TCGA-12-3644	TCGA-12-3644-D23796	1154	1150	null	null	null	null	null	06BG	null	null	30	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	250	mg
TCGA-12-3644	TCGA-12-3644-D23797	1583	1194	null	null	null	null	null	Avastin	null	null	10	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	18900	mg
TCGA-12-3644	TCGA-12-3644-D23798	1611	1583	null	null	null	null	null	Rapamycin	null	null	5	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	140	mg
TCGA-12-3644	TCGA-12-3644-D23799	1611	1583	null	null	null	null	null	Tarceva	null	null	150	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	4200	mg
TCGA-12-3644	TCGA-12-3644-D23800	1611	1583	null	null	null	null	null	Avastin	null	null	10	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	1400	mg
TCGA-12-3644	TCGA-12-3644-D23801	1639	1611	null	null	null	null	null	Rapamycin	null	null	5	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	140	mg
TCGA-12-3644	TCGA-12-3644-D23802	1639	1611	null	null	null	null	null	Tarceva	null	null	150	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	4200	mg
TCGA-12-3644	TCGA-12-3644-D23803	1639	1611	null	null	null	null	null	Avastin	null	null	10	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	1400	mg
TCGA-12-3644	TCGA-12-3644-D23804	1639	1611	null	null	null	null	null	Accutane	null	null	80	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	1680	mg
TCGA-12-3644	TCGA-12-3644-D23805	1722	1639	null	null	null	null	null	Avastin	null	null	10	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	4200	mg
TCGA-12-3644	TCGA-12-3644-D23806	1722	1639	null	null	null	null	null	Acctuane	null	null	80	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	1680	mg
TCGA-12-3644	TCGA-12-3644-D23807	1722	1639	null	null	null	null	null	Chloroquine	null	null	500	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	21000	mg
TCGA-12-3644	TCGA-12-3644-D23808	1806	1765	null	null	null	null	null	Avastin	null	null	10	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	2100	mg
TCGA-12-3644	TCGA-12-3644-D23781	37	37	null	null	null	null	null	Gliadel Wafer	null	01	8	{Wafer}	ADJUVANT	null	Intratumoral	NO	Chemotherapy	null	61.6	{Wafer}
TCGA-12-3644	TCGA-12-3644-D23782	119	72	null	null	null	null	null	Temodar	null	02	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	3200	mg
TCGA-12-3646	TCGA-12-3646-D23813	66	24	null	null	null	null	null	Temodar	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5670	mg
TCGA-12-3646	TCGA-12-3646-D23814	150	90	null	null	null	null	null	Temodar	null	02	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	3600	mg
TCGA-12-3646	TCGA-12-3646-D23815	233	150	null	null	null	null	null	CCNU	null	02	110	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	400	mg
TCGA-12-3646	TCGA-12-3646-D23816	334	247	null	null	null	null	null	CPT 11	null	02	340	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	3610.8	mg
TCGA-12-3646	TCGA-12-3646-D23817	403	334	null	null	null	null	null	Temodar	null	02	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	3500	mg
TCGA-12-3646	TCGA-12-3646-D23818	487	405	null	null	null	null	null	CCNU	null	02	110	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	380	mg
TCGA-12-3646	TCGA-12-3646-D23819	1314	1063	null	null	null	null	null	Temodar	null	08	50	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	17920	mg
TCGA-12-3646	TCGA-12-3646-D23820	334	247	null	null	null	null	null	Avastin	null	null	10	mg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	4182	mg
TCGA-12-3648	TCGA-12-3648-D23824	67	14	null	null	null	null	null	Temodar	null	1	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-12-3648	TCGA-12-3648-D23825	452	126	null	null	null	null	null	Temodar	null	11	100	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	46200	mg
TCGA-12-3648	TCGA-12-3648-D23826	731	508	null	null	null	null	null	CPT 11	null	05	125	mg	RECURRENCE	null	Intravenous (IV)	NO	Chemotherapy	null	3450	mg
TCGA-12-3648	TCGA-12-3648-D23827	784	738	null	null	null	null	null	Temodar	null	1	50	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	2800	mg
TCGA-12-3648	TCGA-12-3648-D23828	784	738	null	null	null	null	null	Vp 16	null	01	50	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	1575	mg
TCGA-12-3648	TCGA-12-3648-D23829	452	83	null	null	null	null	null	PEP3 KLH	null	null	500	ug	ADJUVANT	null	Oral	NO	Immunotherapy	null	6500	ug
TCGA-12-3648	TCGA-12-3648-D23830	731	508	null	null	null	null	null	Avastin	null	null	10	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	10950	mg
TCGA-12-3648	TCGA-12-3648-D23831	784	738	null	null	null	null	null	Avastin	null	null	10	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	1400	mg
TCGA-12-3649	TCGA-12-3649-D23835	null	null	null	null	null	null	null	Temodar	null	03	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6000	mg
TCGA-12-3649	TCGA-12-3649-D23836	240	186	null	null	null	null	null	Temodar	null	01	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	2000	mg
TCGA-12-3649	TCGA-12-3649-D23837	350	240	null	null	null	null	null	Temodar	null	03	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6000	mg
TCGA-12-3649	TCGA-12-3649-D23838	245	186	null	null	null	null	null	ATTAC	null	null	null	null	ADJUVANT	null	null	NO	Immunotherapy	null	null	null
TCGA-12-3649	TCGA-12-3649-D23839	350	240	null	null	null	null	null	ATTAC	null	null	null	null	ADJUVANT	null	null	NO	Immunotherapy	null	null	null
TCGA-12-3649	TCGA-12-3649-D23840	null	null	null	null	null	null	null	Avastin	null	null	10	mg/kg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	null	mg/kg
TCGA-12-3649	TCGA-12-3649-D23841	240	186	null	null	null	null	null	Avastin	null	null	10	mg/kg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	null	mg/kg
TCGA-12-3649	TCGA-12-3649-D23842	347	240	null	null	null	null	null	Avastin	null	null	10	mg/kg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	null	mg/kg
TCGA-12-3650	TCGA-12-3650-D23845	72	26	null	null	null	null	null	Temodar	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6930	mg
TCGA-12-3650	TCGA-12-3650-D23846	148	91	null	null	null	null	null	CPT 11	null	02	340	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	6120	mg
TCGA-12-3650	TCGA-12-3650-D23847	148	91	null	null	null	null	null	Temodar	null	02	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	2000	mg
TCGA-12-3650	TCGA-12-3650-D23848	239	152	null	null	null	null	null	CPT 11	null	03	125	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	1620	mg
TCGA-12-3650	TCGA-12-3650-D23849	239	152	null	null	null	null	null	Temodar	null	03	200	mg	null	null	Oral	NO	Chemotherapy	null	3000	mg
TCGA-12-3650	TCGA-12-3650-D23850	333	307	null	null	null	null	null	VP 16	null	01	50	mg	null	null	Oral	NO	Chemotherapy	null	2100	mg
TCGA-12-3650	TCGA-12-3650-D23851	72	26	null	null	null	null	null	Avastin	null	null	10	mg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	3003	mg
TCGA-12-3650	TCGA-12-3650-D23852	148	91	null	null	null	null	null	Avastin	null	null	10	mg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	3892	mg
TCGA-12-3650	TCGA-12-3650-D23853	239	148	null	null	null	null	null	Avastin	null	null	10	mg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	5838	mg
TCGA-12-3650	TCGA-12-3650-D23854	307	239	null	null	null	null	null	Tarceva	null	null	200	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	11200	mg
TCGA-12-3650	TCGA-12-3650-D23855	307	239	null	null	null	null	null	Avastin	null	null	10	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	3860	mg
TCGA-12-3650	TCGA-12-3650-D23856	333	307	null	null	null	null	null	Avastin	null	null	10	mg	RECURRENCE	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	1894	mg
TCGA-12-3651	TCGA-12-3651-D23860	85	43	null	null	null	null	null	Temodar	null	1	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-12-3651	TCGA-12-3651-D23861	212	186	null	null	null	null	null	Temodar	null	01	150	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	1400	mg
TCGA-12-3651	TCGA-12-3651-D23862	358	221	null	null	null	null	null	CPT 11	null	04	40	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	592	mg
TCGA-12-3651	TCGA-12-3651-D23863	358	221	null	null	null	null	null	Temodar	null	04	150	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5600	mg
TCGA-12-3651	TCGA-12-3651-D23864	85	43	null	null	null	null	null	Avastin	null	null	10	mg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	2430	mg
TCGA-12-3651	TCGA-12-3651-D23865	358	221	null	null	null	null	null	Avastin	null	null	5	mg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	2840	mg
TCGA-12-3652	TCGA-12-3652-D23869	67	21	null	null	null	null	null	Temodar	null	02	150	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	3000	mg
TCGA-12-3652	TCGA-12-3652-D23870	133	91	null	null	null	null	null	CCNU	null	01	110	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	220	mg
TCGA-12-3652	TCGA-12-3652-D23871	203	161	null	null	null	null	null	CCNU	null	01	82.5	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	160	mg
TCGA-12-3652	TCGA-12-3652-D23872	288	228	null	null	null	null	null	Temodar	null	02	200	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	4000	mg
TCGA-12-3652	TCGA-12-3652-D23873	358	291	null	null	null	null	null	VP 16	null	1	50	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	1575	mg
TCGA-12-3652	TCGA-12-3652-D23874	571	469	null	null	null	null	null	VP 16	null	4	50	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	8400	mg
TCGA-12-3652	TCGA-12-3652-D23875	750	585	null	null	null	null	null	Hydroxurea	null	null	500	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	14000	mg
TCGA-12-3652	TCGA-12-3652-D23876	792	750	null	null	null	null	null	Hydroxurea	null	null	500	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	2800	mg
TCGA-12-3652	TCGA-12-3652-D23877	750	585	null	null	null	null	null	Gleevac	null	null	400	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	56000	mg
TCGA-12-3652	TCGA-12-3652-D23878	792	750	null	null	null	null	null	Gleevac	null	null	300	mg	RECURRENCE	null	Oral	NO	Targeted Molecular therapy	null	8400	mg
TCGA-12-3653	TCGA-12-3653-D23882	87	46	null	null	null	null	null	Temodar	null	1	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6300	mg
TCGA-12-3653	TCGA-12-3653-D23883	223	127	null	null	null	null	null	Temodar	null	03	150	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	4500	mg
TCGA-12-3653	TCGA-12-3653-D23884	371	315	null	null	null	null	null	VP 16	null	02	50	mg	null	null	Oral	NO	Chemotherapy	null	4200	mg
TCGA-12-3653	TCGA-12-3653-D23885	223	127	null	null	null	null	null	Daclizumab	null	null	1	mg	ADJUVANT	null	null	NO	Immunotherapy	null	406.4	mg
TCGA-12-3653	TCGA-12-3653-D23886	314	286	null	null	null	null	null	Angiocept	null	null	2	mg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	199	mg
TCGA-12-3653	TCGA-12-3653-D23887	371	315	null	null	null	null	null	Avastin	null	null	10	mg	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	4000	mg
TCGA-12-5295	TCGA-12-5295-D23891	70	28	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	4725	mg
TCGA-12-5295	TCGA-12-5295-D23892	277	87	null	null	null	null	null	CPT 11	null	03	340	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	4590	mg
TCGA-12-5295	TCGA-12-5295-D23893	277	87	null	null	null	null	null	Avastin	null	null	10	mg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	4950	mg
TCGA-12-5295	TCGA-12-5295-D23894	323	277	null	null	null	null	null	Avastin	null	null	10	mg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	1650	mg
TCGA-12-5299	TCGA-12-5299-D23898	80	45	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5250	mg
TCGA-12-5299	TCGA-12-5299-D23899	73	45	null	null	null	null	null	Avastin	null	null	10	mg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	3000	mg
TCGA-12-5301	TCGA-12-5301-D23903	58	24	null	null	null	null	null	Temozolomide	null	01	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5400	mg
TCGA-14-0736	TCGA-14-0736-D25027	null	206	null	null	null	null	null	Gliadel	null	null	null	null	null	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-14-0736	TCGA-14-0736-D25028	376	371	null	null	null	null	null	Temador	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	2000	mg
TCGA-14-0736	TCGA-14-0736-D25029	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	Oral	NO	Hormone Therapy	null	null	null
TCGA-14-0736	TCGA-14-0736-D25030	null	127	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-0740	TCGA-14-0740-D25256	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	mg
TCGA-14-0781	TCGA-14-0781-D25034	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	null	mg
TCGA-14-0783	TCGA-14-0783-D25037	146	31	null	null	null	null	null	Carboxy amido triazole	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	108450	mg
TCGA-14-0783	TCGA-14-0783-D25038	null	-1	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-0786	TCGA-14-0786-D25042	142	140	null	null	null	null	null	Carmustine	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-14-0786	TCGA-14-0786-D25043	142	140	null	null	null	null	null	Cisplatin	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-14-0786	TCGA-14-0786-D25044	210	182	null	null	null	null	null	CPT 11	null	03	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	1124	mg
TCGA-14-0786	TCGA-14-0786-D25045	357	308	null	null	null	null	null	Procarbazine	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	12600	mg
TCGA-14-0786	TCGA-14-0786-D25046	579	526	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg
TCGA-14-0786	TCGA-14-0786-D25047	570	567	null	null	null	null	null	Streptozocin	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	3400	mg
TCGA-14-0786	TCGA-14-0786-D25048	570	567	null	null	null	null	null	6-Mercaptopurine	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	1200	mg
TCGA-14-0786	TCGA-14-0786-D25049	570	567	null	null	null	null	null	Carmustine	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	69	mg
TCGA-14-0786	TCGA-14-0786-D25050	651	574	null	null	null	null	null	Thalidomide	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	300	mg
TCGA-14-0786	TCGA-14-0786-D25051	null	671	null	null	null	null	null	Etoposide	null	null	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-14-0786	TCGA-14-0786-D25052	null	671	null	null	null	null	null	Carboplatin	null	null	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-14-0786	TCGA-14-0786-D25053	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-0786	TCGA-14-0786-D25054	null	127	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	null	Hormone Therapy	null	null	null
TCGA-14-0787	TCGA-14-0787-D25058	41	15	null	null	null	null	null	Dexmethasone	null	null	null	null	ADJUVANT	null	null	null	Hormone Therapy	null	720	mg
TCGA-14-0787	TCGA-14-0787-D25059	null	null	null	null	null	null	null	null	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	null	null
TCGA-14-0789	TCGA-14-0789-D25062	75	44	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	120	mg/day
TCGA-14-0789	TCGA-14-0789-D25063	null	118	null	null	null	null	null	Gliadel Wafer (BCNU)	null	1	null	null	null	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-14-0789	TCGA-14-0789-D25064	118	0	null	null	null	null	null	Dexamethazone	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	2000	mg
TCGA-14-0789	TCGA-14-0789-D25065	224	119	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	Oral	NO	Hormone Therapy	null	1680	mg
TCGA-14-0790	TCGA-14-0790-C1	null	0	null	null	null	CHEMO	null	Gliadel BCNU	null	null	null	null	ADJUVANT	null	OTHER: SPECIFY IN NOTES	NO	null	null	8	{Wafer}
TCGA-14-0790	TCGA-14-0790-C2	409	15	null	null	null	CHEMO	null	Temodar	null	9.0	null	null	ADJUVANT	null	ORAL	NO	null	null	17700	mg
TCGA-14-0790	TCGA-14-0790-H2	null	0	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	null	null	null	mg
TCGA-14-0812	TCGA-14-0812-D25075	null	0	null	null	null	null	null	Gliadel Wafers	null	null	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-14-0812	TCGA-14-0812-D25076	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-0813	TCGA-14-0813-D25079	41	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	16	mg/day
TCGA-14-0817	TCGA-14-0817-D25082	15	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	176	mg
TCGA-14-0862	TCGA-14-0862-D25260	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	mg
TCGA-14-0865	TCGA-14-0865-D25085	167	46	null	null	null	null	null	Temodar	null	04	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	9500	mg
TCGA-14-0865	TCGA-14-0865-D25086	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-0865	TCGA-14-0865-D25087	null	205	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-0866	TCGA-14-0866-D25092	325	21	null	null	null	null	null	Temodar	null	07	null	null	null	null	Oral	NO	Chemotherapy	null	62415	mg
TCGA-14-0866	TCGA-14-0866-D25093	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	null	Hormone Therapy	null	null	null
TCGA-14-0867	TCGA-14-0867-D25097	15	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	24	mg/day
TCGA-14-0871	TCGA-14-0871-D25100	280	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	288	mg
TCGA-14-1034	TCGA-14-1034-D25104	null	448	null	null	null	null	null	Gliadel	null	null	null	null	null	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-14-1034	TCGA-14-1034-D25105	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1034	TCGA-14-1034-D25106	null	274	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1037	TCGA-14-1037-D25110	95	25	null	null	null	null	null	Oxaliplatin	null	06	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg
TCGA-14-1037	TCGA-14-1037-D25111	538	439	null	null	null	null	null	Temodar	null	04	null	null	null	null	Oral	NO	Chemotherapy	null	6000	mg
TCGA-14-1037	TCGA-14-1037-D25112	null	0	null	null	null	null	null	Dexamethasome	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1037	TCGA-14-1037-D25113	null	326	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1037	TCGA-14-1037-D25114	433	346	null	null	null	null	null	PS 341	null	null	null	null	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	36.8	mg
TCGA-14-1043	TCGA-14-1043-D25263	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	mg
TCGA-14-1395	TCGA-14-1395-D25267	28	14	null	null	null	null	null	Oxaliplatin	null	02	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	679	mg
TCGA-14-1395	TCGA-14-1395-D25268	41	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1396	TCGA-14-1396-D25118	null	null	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	null	null
TCGA-14-1401	TCGA-14-1401-D25121	null	null	null	null	null	null	null	Dexamethsone	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	null	null
TCGA-14-1402	TCGA-14-1402-D25124	528	344	null	null	null	null	null	Temodar	null	06	null	null	null	null	Oral	NO	Chemotherapy	null	9500	mg
TCGA-14-1402	TCGA-14-1402-D25125	66	57	null	null	null	null	null	Arsenic Trioxide	null	06	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	63	mg
TCGA-14-1402	TCGA-14-1402-D25126	819	658	null	null	null	null	null	Carboplatin	null	06	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	4969	mg
TCGA-14-1402	TCGA-14-1402-D25127	null	304	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1402	TCGA-14-1402-D25128	null	304	null	null	null	null	null	Prednisone	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	null	null
TCGA-14-1402	TCGA-14-1402-D25129	null	333	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1402	TCGA-14-1402-D25130	632	618	null	null	null	null	null	Sovatenib	null	null	null	null	null	null	Oral	NO	Targeted Molecular therapy	null	14000	mg
TCGA-14-1402	TCGA-14-1402-D25131	819	658	null	null	null	null	null	Avastin	null	null	null	null	null	null	Oral	NO	Targeted Molecular therapy	null	11000	mg
TCGA-14-1450	TCGA-14-1450-D25271	65	22	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5160	mg
TCGA-14-1450	TCGA-14-1450-D25272	961	127	null	null	null	null	null	Temodar	null	15	null	null	null	null	Oral	NO	Chemotherapy	null	19450	mg
TCGA-14-1450	TCGA-14-1450-D25273	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	mg
TCGA-14-1450	TCGA-14-1450-D25274	null	826	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	mg
TCGA-14-1450	TCGA-14-1450-D25275	1233	1024	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	7800	mg
TCGA-14-1451	TCGA-14-1451-D25135	34	20	null	null	null	null	null	Oxaliplatin	null	02	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	641	mg
TCGA-14-1451	TCGA-14-1451-D25136	101	59	null	null	null	null	null	Temodar	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-14-1451	TCGA-14-1451-D25137	null	153	null	null	null	null	null	Gliadel	null	null	null	null	null	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-14-1451	TCGA-14-1451-D25138	480	411	null	null	null	null	null	Cisplatin	null	04	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	780	mg
TCGA-14-1451	TCGA-14-1451-D25139	480	411	null	null	null	null	null	Vincristin	null	04	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	8	mg
TCGA-14-1451	TCGA-14-1451-D25140	480	411	null	null	null	null	null	Etoposide	null	04	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	780	mg
TCGA-14-1451	TCGA-14-1451-D25141	566	501	null	null	null	null	null	BCNU	null	02	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	720	mg
TCGA-14-1451	TCGA-14-1451-D25142	null	-60	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1451	TCGA-14-1451-D25143	null	19	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1451	TCGA-14-1451-D25144	504	382	null	null	null	null	null	Erlotinib	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	9000	mg
TCGA-14-1452	TCGA-14-1452-D25148	null	0	null	null	null	null	null	Gliadel	null	null	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-14-1452	TCGA-14-1452-D25149	185	26	null	null	null	null	null	Temador	null	03	null	null	null	null	Oral	NO	Chemotherapy	null	9,880	mg
TCGA-14-1452	TCGA-14-1452-D25150	null	null	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1452	TCGA-14-1452-D25151	216	172	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1453	TCGA-14-1453-D25155	null	null	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1454	TCGA-14-1454-D25161	899	308	null	null	null	null	null	Hydroxyurea	null	18	null	null	null	null	Oral	NO	Chemotherapy	null	590,000	mg
TCGA-14-1454	TCGA-14-1454-D25162	null	-61	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1454	TCGA-14-1454-D25163	null	290	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1454	TCGA-14-1454-D25158	null	0	null	null	null	null	null	Gliadel	null	null	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-14-1454	TCGA-14-1454-D25159	234	29	null	null	null	null	null	Temodar	null	7	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	15370	mg
TCGA-14-1454	TCGA-14-1454-D25160	899	308	null	null	null	null	null	Gleevac	null	18	null	null	null	null	Oral	NO	Chemotherapy	null	236,000	mg
TCGA-14-1455	TCGA-14-1455-D25167	null	17	null	null	null	null	null	Gliadel wafer	null	null	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-14-1455	TCGA-14-1455-D25168	28	17	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1456	TCGA-14-1456-C2	70	25	null	null	null	CHEMO	null	Arsenic Tnoxide	null	13.0	null	null	ADJUVANT	null	ORAL	NO	null	null	290.94	mg
TCGA-14-1456	TCGA-14-1456-H1	null	0	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	null	null	null	null
TCGA-14-1456	TCGA-14-1456-H2	null	97	null	null	null	HORMONAL	null	Dexamthasone	null	null	null	null	PROGRESSION	null	null	NO	null	null	null	null
TCGA-14-1456	TCGA-14-1456-T1	1128	101	null	null	null	TARGETED	null	Avastin	null	null	null	null	PROGRESSION	null	ORAL	NO	null	null	11704	mg
TCGA-14-1456	TCGA-14-1456-T2	548	101	null	null	null	TARGETED	null	Tarceva	null	null	null	null	PROGRESSION	null	ORAL	NO	null	null	null	null
TCGA-14-1456	TCGA-14-1456-T3	1245	1129	null	null	null	TARGETED	null	Avastin	null	null	null	null	PROGRESSION	null	null	YES	null	null	3344	mg
TCGA-14-1458	TCGA-14-1458-D25180	60	19	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	8400	mg
TCGA-14-1458	TCGA-14-1458-D25181	145	82	null	null	null	null	null	Temodar	null	03	null	null	null	null	Oral	NO	Chemotherapy	null	6450	mg
TCGA-14-1458	TCGA-14-1458-D25182	null	0	null	null	null	null	null	Dexaethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1458	TCGA-14-1458-D25183	null	80	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1458	TCGA-14-1458-D25184	161	88	null	null	null	null	null	Avastin	null	null	null	null	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	10400	mg
TCGA-14-1459	TCGA-14-1459-D25188	554	22	null	null	null	null	null	Temodar	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	9000	mg
TCGA-14-1459	TCGA-14-1459-D25189	null	null	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1459	TCGA-14-1459-D25190	null	null	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1794	TCGA-14-1794-D25194	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1795	TCGA-14-1795-D25198	null	0	null	null	null	null	null	Gliadel Wafer	null	null	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-14-1795	TCGA-14-1795-D25199	59	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1821	TCGA-14-1821-D25202	68	39	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5400	mg
TCGA-14-1821	TCGA-14-1821-D25203	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1821	TCGA-14-1821-D25204	null	331	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1823	TCGA-14-1823-D25208	449	20	null	null	null	null	null	Temodar	null	12	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	11150	mg
TCGA-14-1823	TCGA-14-1823-D25209	null	0	null	null	null	null	null	Gliadel Wafers	null	null	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	8	{Wafer}
TCGA-14-1823	TCGA-14-1823-D25210	449	20	null	null	null	null	null	Temodar	null	12	null	null	null	null	Oral	NO	Chemotherapy	null	null	null
TCGA-14-1823	TCGA-14-1823-D25211	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1823	TCGA-14-1823-D25212	null	139	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1823	TCGA-14-1823-D25213	477	378	null	null	null	null	null	Avastin	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	6400	mg
TCGA-14-1825	TCGA-14-1825-D25217	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1825	TCGA-14-1825-D25218	null	91	null	null	null	null	null	Dexamethasone	null	null	null	null	null	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1827	TCGA-14-1827-D25222	46	42	null	null	null	null	null	Cisplatin	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-14-1827	TCGA-14-1827-D25223	46	42	null	null	null	null	null	BCNU	null	01	null	null	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-14-1827	TCGA-14-1827-D25224	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-1829	TCGA-14-1829-D25227	null	8	null	null	null	null	null	Temodar	null	04	null	null	ADJUVANT	null	Oral	YES	Chemotherapy	null	10040	mg
TCGA-14-1829	TCGA-14-1829-D25228	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	null
TCGA-14-2554	TCGA-14-2554-H1	null	0	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	null	null	null	mg
TCGA-14-2555	TCGA-14-2555-D25236	242	34	null	null	null	null	null	Temodar	null	04	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	12600	mg
TCGA-14-2555	TCGA-14-2555-D25237	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	null	mg
TCGA-14-3476	TCGA-14-3476-D25241	30	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	Intravenous (IV)	NO	Hormone Therapy	null	null	mg
TCGA-14-3477	TCGA-14-3477-D25244	67	35	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	4480	mg
TCGA-14-3477	TCGA-14-3477-D25245	null	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	null	Hormone Therapy	null	null	mg
TCGA-14-3477	TCGA-14-3477-D25246	70	56	null	null	null	null	null	Avastin	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	1480	mg
TCGA-14-4157	TCGA-14-4157-D25250	66	18	null	null	null	null	null	Temodar	null	null	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	3600	mg
TCGA-14-4157	TCGA-14-4157-D25251	null	95	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	YES	Chemotherapy	null	355	mg
TCGA-14-4157	TCGA-14-4157-D25252	null	null	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	Oral	NO	Hormone Therapy	null	null	mg
TCGA-15-0742	TCGA-15-0742-D25279	59	28	null	null	null	null	null	Temozolamide	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2/day
TCGA-15-0742	TCGA-15-0742-D25280	300	259	null	null	null	null	null	SAHA	null	null	null	null	ADJUVANT	null	null	NO	Targeted Molecular therapy	null	200	mg
TCGA-15-1446	TCGA-15-1446-D25284	273	61	null	null	null	null	null	Temudar	null	06	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-15-1447	TCGA-15-1447-D25288	130	9	null	null	null	null	null	CPT-11	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-15-1447	TCGA-15-1447-D25289	130	9	null	null	null	null	null	BCNU	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-15-1447	TCGA-15-1447-D25290	130	9	null	null	null	null	null	Temudar	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-15-1449	TCGA-15-1449-D25294	74	32	null	null	null	null	null	Temudar	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-19-0955	TCGA-19-0955-D25336	274	31	null	null	null	null	null	Temozolomide	null	6	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	360	mg
TCGA-19-0957	TCGA-19-0957-D25341	579	565	null	null	null	null	null	Avastin	null	02	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	1660	mg
TCGA-19-0957	TCGA-19-0957-D25342	81	35	null	null	null	null	null	Temozolomide	null	06	null	null	null	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-19-0957	TCGA-19-0957-D25343	274	121	null	null	null	null	null	Temozolomide	null	06	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	9000	mg
TCGA-19-0957	TCGA-19-0957-D25344	372	368	null	null	null	null	null	Temozolomide	null	01	null	null	RECURRENCE	null	Oral	NO	Chemotherapy	null	1500	mg
TCGA-19-0957	TCGA-19-0957-D25345	551	537	null	null	null	null	null	Avastin	null	02	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	1660	mg
TCGA-19-0957	TCGA-19-0957-D25346	551	537	null	null	null	null	null	Irinotecan	null	02	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	470	mg
TCGA-19-0957	TCGA-19-0957-D25347	607	593	null	null	null	null	null	Avastin	null	02	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	1660	mg
TCGA-19-0957	TCGA-19-0957-D25348	607	593	null	null	null	null	null	Irinotecan	null	02	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	470	mg
TCGA-19-0960	TCGA-19-0960-D25352	null	41	null	null	null	null	null	Temodar	null	5	null	null	ADJUVANT	null	Oral	null	Chemotherapy	null	300	mg
TCGA-19-0963	TCGA-19-0963-D25358	84	34	null	null	null	null	null	Temodar	null	1	120	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5160	mg
TCGA-19-0963	TCGA-19-0963-D25359	270	129	null	null	null	null	null	Temodar	null	5	260	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6500	mg
TCGA-19-0964	TCGA-19-0964-D25363	82	39	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	140	mg
TCGA-19-1385	TCGA-19-1385-D25367	92	88	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1600	mg
TCGA-19-1385	TCGA-19-1385-D25368	57	16	null	null	null	null	null	Temozolomide	null	06	null	null	null	null	Oral	NO	Chemotherapy	null	6300	mg
TCGA-19-1386	TCGA-19-1386-D25372	236	230	null	null	null	null	null	Tarceva	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1050	mg
TCGA-19-1386	TCGA-19-1386-D25373	62	21	null	null	null	null	null	Temozolomide	null	4	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-19-1386	TCGA-19-1386-D25374	93	89	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1500	mg
TCGA-19-1386	TCGA-19-1386-D25375	244	152	null	null	null	null	null	Temozolomide	null	04	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	6000	mg
TCGA-19-1386	TCGA-19-1386-D25376	229	216	null	null	null	null	null	Tarceva	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1800	mg
TCGA-19-1387	TCGA-19-1387-D25380	58	19	null	null	null	null	null	Temozolomide	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	5600	mg
TCGA-19-1388	TCGA-19-1388-D25384	377	363	null	null	null	null	null	Avastin	null	02	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	1750	mg
TCGA-19-1388	TCGA-19-1388-D25385	63	21	null	null	null	null	null	Temozolomide	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	6020	mg
TCGA-19-1388	TCGA-19-1388-D25386	245	92	null	null	null	null	null	Temozolomide	null	06	null	null	null	null	Oral	NO	Chemotherapy	null	9000	mg
TCGA-19-1388	TCGA-19-1388-D25387	328	269	null	null	null	null	null	Temozolomide	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	6000	mg
TCGA-19-1389	TCGA-19-1389-D25391	67	48	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	3600	mg
TCGA-19-1389	TCGA-19-1389-D25392	20	10	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1980	mg
TCGA-19-1389	TCGA-19-1389-D25393	41	26	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	2880	mg
TCGA-19-1787	TCGA-19-1787-D25404	85	42	null	null	null	null	null	Temodar	null	1	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-19-1787	TCGA-19-1787-D25405	263	111	null	null	null	null	null	Temodar	null	06	280	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	9200	mg
TCGA-19-1787	TCGA-19-1787-D25406	347	311	null	null	null	null	null	Avastin	null	03	10	mg	RECURRENCE	null	Intravenous (IV)	NO	Chemotherapy	null	900	mg
TCGA-19-1787	TCGA-19-1787-D25407	85	42	null	null	null	null	null	Temodar	null	01	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-19-1788	TCGA-19-1788-D25411	94	50	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-19-1789	TCGA-19-1789-D25415	32	26	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	980	mg
TCGA-19-1790	TCGA-19-1790-D25419	66	25	null	null	null	null	null	Temozolomide	null	1	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-19-2619	TCGA-19-2619-D25425	85	57	null	null	null	null	null	Temozolomide	null	1	125	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	3625	mg
TCGA-19-2619	TCGA-19-2619-D25426	117	113	null	null	null	null	null	Temozolomide	null	1	250	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	1250	mg
TCGA-19-2619	TCGA-19-2619-D25427	295	153	null	null	null	null	null	Avastin	null	10	630	mg	null	null	Intravenous (IV)	NO	Chemotherapy	null	630	mg
TCGA-19-2620	TCGA-19-2620-D25432	51	33	null	null	null	null	null	Temozolomide	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-19-2623	TCGA-19-2623-D25438	53	25	null	null	null	null	null	Temodar	null	1	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	4060	mg
TCGA-19-2623	TCGA-19-2623-D25439	114	110	null	null	null	null	null	Temodar	null	1	280	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	1400	mg
TCGA-19-2623	TCGA-19-2623-D25440	null	92	null	null	null	null	null	Temodar	null	5	240	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	1200	mg
TCGA-19-2629	TCGA-19-2629-D25448	69	10	null	null	null	null	null	Temodar	null	1	180	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	7560	mg
TCGA-19-2629	TCGA-19-2629-D25449	122	91	null	null	null	null	null	Temodar	null	2	350	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	3500	mg
TCGA-19-2629	TCGA-19-2629-D25450	198	148	null	null	null	null	null	Avastin	null	4	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-19-4065	TCGA-19-4065-D25512	70	39	null	null	null	null	null	Temozolomide	null	1	180	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5400	mg
TCGA-19-4065	TCGA-19-4065-D25513	89	78	null	null	null	null	null	Temozolomide	null	1	180	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	2160	mg
TCGA-19-4065	TCGA-19-4065-D25514	128	123	null	null	null	null	null	Temozolomide	null	1	360	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	1800	mg
TCGA-19-4065	TCGA-19-4065-D25515	170	166	null	null	null	null	null	Temozolomide	null	1	480	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	2400	mg
TCGA-19-4068	TCGA-19-4068-D25457	74	60	null	null	null	null	null	Temodar	null	1	105	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	1200	mg
TCGA-19-4068	TCGA-19-4068-D25458	108	82	null	null	null	null	null	Temodar	null	1	105	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	2835	mg
TCGA-19-5950	TCGA-19-5950-D25466	70	27	null	null	null	null	null	Temodar	null	null	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6020	mg
TCGA-19-5950	TCGA-19-5950-D25467	110	106	null	null	null	null	null	Temodar	null	1	270	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	1350	mg
TCGA-19-5950	TCGA-19-5950-D25468	249	134	null	null	null	null	null	Temodar	null	5	350	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	8750	mg
TCGA-19-5951	TCGA-19-5951-D25472	94	50	null	null	null	null	null	Temodar	null	null	165	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6270	mg
TCGA-19-5954	TCGA-19-5954-D25479	75	32	null	null	null	null	null	Temodar	null	null	135	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5805	mg
TCGA-19-5954	TCGA-19-5954-D25480	107	103	null	null	null	null	null	Temodar	null	1	270	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	1350	mg
TCGA-19-5956	TCGA-19-5956-D25486	70	51	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-19-5956	TCGA-19-5956-D25487	206	202	null	null	null	null	null	Temodar	null	1	240	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	1200	mg
TCGA-19-5958	TCGA-19-5958-D25491	80	34	null	null	null	null	null	Temodar	null	null	145	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6090	mg
TCGA-19-5958	TCGA-19-5958-D25492	115	111	null	null	null	null	null	Temodar	null	1	300	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	1500	mg
TCGA-19-5958	TCGA-19-5958-D25493	null	139	null	null	null	null	null	Temodar	null	null	400	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	2000	mg
TCGA-19-5958	TCGA-19-5958-D25494	null	56	null	null	null	null	null	Avastin	null	null	null	null	ADJUVANT	null	Intravenous (IV)	YES	Chemotherapy	null	null	null
TCGA-19-5959	TCGA-19-5959-D25498	88	73	null	null	null	null	null	Temodar	null	null	125	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	2125	mg
TCGA-19-5959	TCGA-19-5959-D25499	135	131	null	null	null	null	null	Temodar	null	1	160	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	800	mg
TCGA-19-5959	TCGA-19-5959-D25500	null	174	null	null	null	null	null	Temodar	null	null	250	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	1250	mg
TCGA-19-5960	TCGA-19-5960-D25504	71	30	null	null	null	null	null	Temodar	null	null	135	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5670	mg
TCGA-19-5960	TCGA-19-5960-D25505	null	123	null	null	null	null	null	Temodar	null	2	280	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	1400	mg
TCGA-19-5960	TCGA-19-5960-D25506	null	53	null	null	null	null	null	Avastin	null	4	635	mg	ADJUVANT	null	Intravenous (IV)	YES	Chemotherapy	null	4445	mg
TCGA-26-1438	TCGA-26-1438-D26847	73	31	null	null	null	null	null	Temozolomide	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5670	mg
TCGA-26-1438	TCGA-26-1438-D26848	206	104	null	null	null	null	null	Temozolomide	null	04	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1440	mg
TCGA-26-1438	TCGA-26-1438-D26849	221	221	null	null	null	null	null	Lomustine	null	01	null	null	null	null	Oral	NO	Chemotherapy	null	210	mg
TCGA-26-1438	TCGA-26-1438-D26850	264	221	null	null	null	null	null	Recentin Placebo AXDX2171	null	null	null	null	null	null	null	NO	Targeted Molecular therapy	null	880	mg
TCGA-26-1439	TCGA-26-1439-D26854	81	31	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-26-1440	TCGA-26-1440-D26858	78	30	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	6300	mg
TCGA-26-1440	TCGA-26-1440-D26859	null	108	null	null	null	null	null	Temozolomide	null	08	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	3140	mg
TCGA-26-1442	TCGA-26-1442-D26890	66	27	null	null	null	null	null	Motexafin Gadolinium	null	22	340	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	7480	mg
TCGA-26-1442	TCGA-26-1442-D26891	66	27	null	null	null	null	null	Temodar	null	01	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5600	mg
TCGA-26-1442	TCGA-26-1442-D26892	872	94	null	null	null	null	null	Temodar	null	27	200	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	27000	mg/m2
TCGA-26-1443	TCGA-26-1443-D26863	79	32	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5460	mg
TCGA-26-1443	TCGA-26-1443-D26864	194	111	null	null	null	null	null	Temozolomide	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	915	mg
TCGA-26-1799	TCGA-26-1799-D26868	148	101	null	null	null	null	null	Temodar	null	02	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	4150	mg
TCGA-26-5132	TCGA-26-5132-D26872	83	40	null	null	null	null	null	Temozolomide	null	1	110	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	4620	mg
TCGA-26-5132	TCGA-26-5132-D26873	212	212	null	null	null	null	null	Temozolomide	null	1	150	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-26-5133	TCGA-26-5133-D26877	68	25	null	null	null	null	null	Temozolamide	null	1	75	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	3300	mg/m2
TCGA-26-5133	TCGA-26-5133-D26878	120	116	null	null	null	null	null	Temozolomide	null	1	150	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	750	mg/m2
TCGA-26-5133	TCGA-26-5133-D26879	351	144	null	null	null	null	null	Temozolomide	null	8	200	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	8000	mg/m2
TCGA-26-6173	TCGA-26-6173-D26896	null	24	null	null	null	null	null	Cilengitide	null	30	4000	mg	ADJUVANT	null	Intravenous (IV)	YES	Chemotherapy	null	120000	mg
TCGA-26-6173	TCGA-26-6173-D26897	70	31	null	null	null	null	null	Temozolomide	null	75	75	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	2250	mg/m2
TCGA-26-6173	TCGA-26-6173-D26898	105	101	null	null	null	null	null	Temozolomide	null	01	150	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	750	mg/m2
TCGA-26-6173	TCGA-26-6173-D26899	245	129	null	null	null	null	null	Temozolomide	null	05	200	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	1000	mg/m2
TCGA-26-6174	TCGA-26-6174-D26903	65	29	null	null	null	null	null	Temozolomide	null	06	75	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	2850	mg/m2
TCGA-27-1830	TCGA-27-1830-D26907	86	8	null	null	null	null	null	Cisplatin	null	03	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	420	mg
TCGA-27-1830	TCGA-27-1830-D26908	86	8	null	null	null	null	null	Temozolomide	null	03	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	3750	mg
TCGA-27-1830	TCGA-27-1830-D26909	70	-1	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	4	mg/day
TCGA-27-1831	TCGA-27-1831-C2	97	4	null	null	null	CHEMO	null	Cisplatin	null	3.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	NO	null	null	420	mg
TCGA-27-1831	TCGA-27-1831-C3	102	6	null	null	null	CHEMO	null	Temozolomide	null	3.0	null	null	ADJUVANT	null	ORAL	NO	null	null	3400	mg
TCGA-27-1831	TCGA-27-1831-H1	504	-8	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	OTHER: SPECIFY IN NOTES	NO	null	null	4104	mg
TCGA-27-1831	TCGA-27-1831-H2	504	-8	null	null	null	HORMONAL	null	Oxcarbazepine	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	307800	mg
TCGA-27-1832	TCGA-27-1832-D26921	214	30	null	null	null	null	null	Temozolomide	null	3	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	3600	mg
TCGA-27-1832	TCGA-27-1832-D26922	214	214	null	null	null	null	null	Temozolomide	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1200	mg
TCGA-27-1832	TCGA-27-1832-D26923	300	0	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	8	mg/day
TCGA-27-1833	TCGA-27-1833-D26927	609	184	null	null	null	null	null	Cisplatin	null	04	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	320	mg
TCGA-27-1833	TCGA-27-1833-D26928	609	184	null	null	null	null	null	Temozolomide	null	04	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	3500	mg
TCGA-27-1833	TCGA-27-1833-D26929	359	184	null	null	null	null	null	Fotemustine	null	06	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	208	mg
TCGA-27-1833	TCGA-27-1833-D26930	725	184	null	null	null	null	null	Procarbazine	null	06	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	1300	mg
TCGA-27-1833	TCGA-27-1833-D26931	737	-6	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	8	mg/day
TCGA-27-1834	TCGA-27-1834-D26935	539	365	null	null	null	null	null	Procarbazine	null	06	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	1248	mg
TCGA-27-1834	TCGA-27-1834-D26936	662	365	null	null	null	null	null	Temozolomide	null	null	null	null	ADJUVANT	null	Oral	YES	Chemotherapy	null	35000	mg
TCGA-27-1834	TCGA-27-1834-D26937	539	365	null	null	null	null	null	Fotemustine	null	06	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	1200	mg
TCGA-27-1834	TCGA-27-1834-D26938	180	28	null	null	null	null	null	Temozolomoide	null	5	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	6250	mg
TCGA-27-1834	TCGA-27-1834-D26939	180	28	null	null	null	null	null	Cisplatin	null	5	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	320	mg
TCGA-27-1834	TCGA-27-1834-D26940	1232	-5	null	null	null	null	null	Dexamethasone	null	null	null	null	ADJUVANT	null	null	NO	Hormone Therapy	null	7302	mg
TCGA-27-1835	TCGA-27-1835-C2	3	2	null	null	null	CHEMO	null	Cisplatin	null	1.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	NO	null	null	160	mg
TCGA-27-1835	TCGA-27-1835-C3	153	4	null	null	null	CHEMO	null	Temozolomide	null	3.0	null	null	ADJUVANT	null	ORAL	NO	null	null	4300	mg
TCGA-27-1835	TCGA-27-1835-C4	457	206	null	null	null	CHEMO	null	PC2	null	5.0	null	null	RECURRENCE	null	ORAL	NO	null	null	8400	mg
TCGA-27-1835	TCGA-27-1835-C5	208	208	null	null	null	CHEMO	null	FT	null	1.0	null	null	RECURRENCE	null	INTRAVENOUS (IV)	NO	null	null	12	mL
TCGA-27-1835	TCGA-27-1835-C6	270	270	null	null	null	CHEMO	null	BCNU	null	1.0	null	null	RECURRENCE	null	INTRAVENOUS (IV)	NO	null	null	200	mg
TCGA-27-1835	TCGA-27-1835-H1	648	-7	null	null	null	HORMONAL	null	Levetiracetam	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	654000	mg
TCGA-27-1835	TCGA-27-1835-H2	648	-7	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	1308	mg
TCGA-27-1836	TCGA-27-1836-C2	90	48	null	null	null	CHEMO	null	Temozolomide	null	7.0	null	null	ADJUVANT	null	ORAL	NO	null	null	5880	mg
TCGA-27-1836	TCGA-27-1836-C3	184	123	null	null	null	CHEMO	null	Temozolomide	null	3.0	null	null	ADJUVANT	null	ORAL	NO	null	null	8400	mg
TCGA-27-1836	TCGA-27-1836-C4	399	245	null	null	null	CHEMO	null	PCB	null	5.0	null	null	ADJUVANT	null	ORAL	NO	null	null	3550	mg
TCGA-27-1836	TCGA-27-1836-C5	399	247	null	null	null	CHEMO	null	Fotemustine	null	5.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	NO	null	null	896	mg
TCGA-27-1836	TCGA-27-1836-C6	562	472	null	null	null	CHEMO	null	Temozolomide	null	3.0	null	null	ADJUVANT	null	ORAL	NO	null	null	8400	mg
TCGA-27-1836	TCGA-27-1836-C7	760	655	null	null	null	CHEMO	null	Bevacizumab	null	8.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	NO	null	null	6720	mg
TCGA-27-1836	TCGA-27-1836-C8	760	655	null	null	null	CHEMO	null	Irunotecan	null	7.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	NO	null	null	1440	mg
TCGA-27-1836	TCGA-27-1836-H1	914	-7	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	22080	mg
TCGA-27-1836	TCGA-27-1836-H2	914	-7	null	null	null	HORMONAL	null	Valproic Acid	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	828000	mg
TCGA-27-1837	TCGA-27-1837-C2	147	-1	null	null	null	CHEMO	null	CDDP	null	5.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	NO	null	null	800	mg
TCGA-27-1837	TCGA-27-1837-C3	152	1	null	null	null	CHEMO	null	Temozolomide	null	5.0	null	null	ADJUVANT	null	ORAL	NO	null	null	8750	mg
TCGA-27-1837	TCGA-27-1837-C4	105	35	null	null	null	CHEMO	null	Doxorubicin	null	4.0	null	null	ADJUVANT	null	OTHER: SPECIFY IN NOTES	NO	null	null	16	mg
TCGA-27-1837	TCGA-27-1837-H1	427	-6	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	2592	mg
TCGA-27-1838	TCGA-27-1838-C2	2	1	null	null	null	CHEMO	null	Cisplatin	null	1.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	NO	null	null	140	mg
TCGA-27-1838	TCGA-27-1838-C3	7	3	null	null	null	CHEMO	null	Temozolomide	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	1500	mg
TCGA-27-1838	TCGA-27-1838-H1	350	-11	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	OTHER: SPECIFY IN NOTES	NO	null	null	2214	mg
TCGA-27-1838	TCGA-27-1838-H2	350	-11	null	null	null	HORMONAL	null	Oxcarbazepine	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	216600	mg
TCGA-27-2518	TCGA-27-2518-C1	181	21	null	null	null	CHEMO	null	Temozolomide	null	5.0	null	null	ADJUVANT	null	ORAL	NO	null	null	8750	mg
TCGA-27-2518	TCGA-27-2518-C2	106	19	null	null	null	CHEMO	null	Cisplatin	null	3.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	NO	null	null	500	mg
TCGA-27-2518	TCGA-27-2518-C3	700	627	null	null	null	CHEMO	null	PC2	null	3.0	null	null	RECURRENCE	null	ORAL	NO	null	null	3600	mg
TCGA-27-2518	TCGA-27-2518-C4	700	627	null	null	null	CHEMO	null	Fotemustine	null	3.0	null	null	RECURRENCE	null	INTRAVENOUS (IV)	NO	null	null	580	mg
TCGA-27-2518	TCGA-27-2518-H1	752	54	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	OTHER: SPECIFY IN NOTES	NO	null	null	5576	mg
TCGA-27-2518	TCGA-27-2518-H2	752	54	null	null	null	HORMONAL	null	Levenracetam	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	1045500	mg
TCGA-27-2519	TCGA-27-2519-C1	95	49	null	null	null	CHEMO	null	Temozolomide	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	6440	mg
TCGA-27-2519	TCGA-27-2519-C2	259	133	null	null	null	CHEMO	null	Temozolomide	null	5.0	null	null	ADJUVANT	null	ORAL	NO	null	null	7500	mg
TCGA-27-2519	TCGA-27-2519-C3	null	302	null	null	null	CHEMO	null	Fotemustina	null	3.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	YES	null	null	390	mg
TCGA-27-2519	TCGA-27-2519-H1	null	-10	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	ORAL	YES	null	null	null	mg
TCGA-27-2519	TCGA-27-2519-H2	null	-10	null	null	null	HORMONAL	null	Levetiracetam	null	null	null	null	ADJUVANT	null	ORAL	YES	null	null	null	mg
TCGA-27-2521	TCGA-27-2521-C1	null	91	null	null	null	CHEMO	null	Temozolomide	null	8.0	null	null	ADJUVANT	null	ORAL	YES	null	null	14000	mg
TCGA-27-2521	TCGA-27-2521-H1	null	-15	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	ORAL	YES	null	null	null	mg
TCGA-27-2521	TCGA-27-2521-H2	null	-15	null	null	null	HORMONAL	null	Levetiracetam	null	null	null	null	ADJUVANT	null	ORAL	YES	null	null	null	mg
TCGA-27-2523	TCGA-27-2523-C1	59	10	null	null	null	CHEMO	null	Cisplatin	null	2.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	NO	null	null	315	mg
TCGA-27-2523	TCGA-27-2523-C2	11	11	null	null	null	CHEMO	null	Lumustine	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	160	mg
TCGA-27-2523	TCGA-27-2523-C3	380	60	null	null	null	CHEMO	null	Temozolomide	null	10.0	null	null	ADJUVANT	null	ORAL	NO	null	null	15000	mg
TCGA-27-2523	TCGA-27-2523-C4	396	97	null	null	null	CHEMO	null	Erlotinib	null	10.0	null	null	ADJUVANT	null	ORAL	NO	null	null	1500	mg
TCGA-27-2523	TCGA-27-2523-H1	489	-6	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	3960	mg
TCGA-27-2523	TCGA-27-2523-H2	489	-6	null	null	null	HORMONAL	null	Phenytoin Sodium	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	148500	mg
TCGA-27-2524	TCGA-27-2524-C1	-6	-6	null	null	null	CHEMO	null	Gliadel Wafer	null	null	null	null	ADJUVANT	null	OTHER: SPECIFY IN NOTES	NO	null	null	61.6	{Wafer}
TCGA-27-2524	TCGA-27-2524-C2	119	58	null	null	null	CHEMO	null	Temozolomide	null	3.0	null	null	ADJUVANT	null	ORAL	NO	null	null	7500	mg
TCGA-27-2524	TCGA-27-2524-H1	231	-6	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	OTHER: SPECIFY IN NOTES	NO	null	null	948	mg
TCGA-27-2524	TCGA-27-2524-H2	231	-6	null	null	null	HORMONAL	null	Oxcarbazepine	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	142200	mg
TCGA-27-2526	TCGA-27-2526-H1	87	-6	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	OTHER: SPECIFY IN NOTES	NO	null	null	744	mg
TCGA-27-2527	TCGA-27-2527-H1	438	-7	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	3552	mg
TCGA-27-2527	TCGA-27-2527-H2	438	-7	null	null	null	HORMONAL	null	Valproic acid	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	444000	mg
TCGA-27-2528	TCGA-27-2528-C1	149	-2	null	null	null	CHEMO	null	Cisplatin	null	4.0	null	null	ADJUVANT	null	INTRAVENOUS (IV)	NO	null	null	510	mg
TCGA-27-2528	TCGA-27-2528-C2	160	0	null	null	null	CHEMO	null	Temozolomide	null	4.0	null	null	ADJUVANT	null	ORAL	NO	null	null	6000	mg
TCGA-27-2528	TCGA-27-2528-C3	464	444	null	null	null	CHEMO	null	Temozolomide	null	1.0	null	null	RECURRENCE	null	ORAL	NO	null	null	1960	mg
TCGA-27-2528	TCGA-27-2528-H1	479	-12	null	null	null	HORMONAL	null	Dexamethasone	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	3928	mg
TCGA-27-2528	TCGA-27-2528-H2	479	-12	null	null	null	HORMONAL	null	Levetiracetam	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	603500	mg
TCGA-28-1745	TCGA-28-1745-D27039	179	14	null	null	null	null	null	Temozolomide	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	7000	mg
TCGA-28-1745	TCGA-28-1745-D27040	179	14	null	null	null	null	null	Temozolomide	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	4500	mg
TCGA-28-1745	TCGA-28-1745-D27041	179	14	null	null	null	null	null	Temozolomide	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	2000	mg
TCGA-28-1747	TCGA-28-1747-C2	36	25	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg
TCGA-28-1749	TCGA-28-1749-D27052	158	19	null	null	null	null	null	Temozolomide	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	4400	mg
TCGA-28-1749	TCGA-28-1749-D27053	158	19	null	null	null	null	null	Temozolomide	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	7560	mg
TCGA-28-1749	TCGA-28-1749-D27054	158	19	null	null	null	null	null	Temozolomide	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	3800	mg
TCGA-28-1750	TCGA-28-1750-D27058	115	10	null	null	null	null	null	Temozolomide	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5040	mg
TCGA-28-1750	TCGA-28-1750-D27059	115	10	null	null	null	null	null	Temozolomide	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1250	mg
TCGA-28-1750	TCGA-28-1750-D27060	115	10	null	null	null	null	null	Temozolomide	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1700	mg
TCGA-28-1751	TCGA-28-1751-D27065	207	14	null	null	null	null	null	Temozolomide	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	6300	mg
TCGA-28-1751	TCGA-28-1751-D27066	207	14	null	null	null	null	null	Temozolomide	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	2600	mg
TCGA-28-1751	TCGA-28-1751-D27067	207	14	null	null	null	null	null	Temozolomide	null	03	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	2100	mg
TCGA-28-1751	TCGA-28-1751-D27068	141	113	null	null	null	null	null	Dendriticcell Vaccine	null	null	null	null	ADJUVANT	null	null	NO	Immunotherapy	null	3	null
TCGA-28-1752	TCGA-28-1752-D27072	272	11	null	null	null	null	null	Temozolomide	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-28-1752	TCGA-28-1752-D27073	272	11	null	null	null	null	null	Temozolomide	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1800	mg
TCGA-28-1752	TCGA-28-1752-D27074	272	11	null	null	null	null	null	Temozolomide	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	1440	mg
TCGA-28-1752	TCGA-28-1752-D27075	272	11	null	null	null	null	null	Temozolomide	null	05	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	3000	mg
TCGA-28-1752	TCGA-28-1752-D27076	131	104	null	null	null	null	null	Dendriticcell Vaccine	null	null	null	null	ADJUVANT	null	null	NO	Immunotherapy	null	3	null
TCGA-28-1755	TCGA-28-1755-D27083	56	14	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	5040	mg
TCGA-28-1756	TCGA-28-1756-C2	69	21	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg
TCGA-28-1760	TCGA-28-1760-D27093	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	100	mg
TCGA-28-1760	TCGA-28-1760-D27094	null	105	null	null	null	null	null	Avastin	null	null	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	1100	mg
TCGA-28-1760	TCGA-28-1760-D27095	null	250	null	null	null	null	null	Tarceva	null	null	null	null	ADJUVANT	null	Intravenous (IV)	null	Chemotherapy	null	150	mg
TCGA-28-2506	TCGA-28-2506-C1	72	27	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/m2
TCGA-28-2506	TCGA-28-2506-I1	135	107	null	null	null	IMMUNO	null	Tumor Vaccine	null	null	null	null	ADJUVANT	null	OTHER: SPECIFY IN NOTES	NO	null	null	null	mL
TCGA-28-2506	TCGA-28-2506-T1	null	177	null	null	null	TARGETED	null	BIBW 2992	null	null	null	null	PROGRESSION	null	ORAL	YES	null	null	null	mg
TCGA-28-2509	TCGA-28-2509-C1	null	33	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	YES	null	null	null	mg/m2
TCGA-28-2509	TCGA-28-2509-T1	null	26	null	null	null	TARGETED	null	Cilenaitide	null	null	null	null	ADJUVANT	null	INTRAVENOUS (IV)	YES	null	null	null	mg/day
TCGA-28-2513	TCGA-28-2513-C1	57	28	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/day
TCGA-28-2513	TCGA-28-2513-C2	null	44	null	null	null	CHEMO	null	Temodar	null	null	null	null	RECURRENCE	null	ORAL	YES	null	null	null	mg/day
TCGA-28-2513	TCGA-28-2513-T1	null	44	null	null	null	TARGETED	null	Avastin	null	null	null	null	RECURRENCE	null	INTRAVENOUS (IV)	YES	null	null	460	mg
TCGA-28-2514	TCGA-28-2514-C1	null	29	null	null	null	CHEMO	null	Temozolomide	null	null	null	null	ADJUVANT	null	ORAL	YES	null	null	null	mg/m2
TCGA-28-5204	TCGA-28-5204-D15042	448	9	null	null	null	null	null	Temodar	null	unknown	140	mg	ADJUVANT	01	Oral	NO	Chemotherapy	null	8160	mg
TCGA-28-5204	TCGA-28-5204-D28859	448	9	null	null	null	null	null	Temodar	null	null	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	8160	mg
TCGA-28-5207	TCGA-28-5207-D15034	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-28-5207	TCGA-28-5207-D28863	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-28-5207	TCGA-28-5207-D28864	null	null	null	null	null	null	null	null	null	null	null	null	PROGRESSION	null	null	null	Chemotherapy	null	null	null
TCGA-28-5208	TCGA-28-5208-D15531	434	275	null	null	null	null	null	Avastin	null	05	10	mg/kg	RECURRENCE	03	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-28-5208	TCGA-28-5208-D15029	48	11	null	null	null	null	null	Temodar	null	01	140	mg	ADJUVANT	01	Oral	NO	Chemotherapy	null	5320	mg
TCGA-28-5208	TCGA-28-5208-D16141	434	275	null	null	null	null	null	CPT11	null	05	Unknown	null	RECURRENCE	03	null	NO	Chemotherapy	null	Unknown	null
TCGA-28-5208	TCGA-28-5208-D16142	285	148	null	null	null	null	null	Temodar	null	05	390	mg	RECURRENCE	02	Oral	NO	Chemotherapy	null	9750	mg
TCGA-28-5208	TCGA-28-5208-D28869	48	11	null	null	null	null	null	Temodar	null	01	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5320	mg
TCGA-28-5208	TCGA-28-5208-D28870	434	275	null	null	null	null	null	Avastin	null	05	10	null	RECURRENCE	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-28-5208	TCGA-28-5208-D28871	434	275	null	null	null	null	null	CPT11	null	05	null	null	RECURRENCE	null	null	NO	Chemotherapy	null	null	null
TCGA-28-5208	TCGA-28-5208-D28872	285	148	null	null	null	null	null	Temodar	null	05	390	mg	RECURRENCE	null	Oral	NO	Chemotherapy	null	9750	mg
TCGA-28-5209	TCGA-28-5209-D15025	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-28-5209	TCGA-28-5209-D28877	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-28-5211	TCGA-28-5211-D15532	307	244	null	null	null	null	null	Avastin	null	02	Unknown	null	RECURRENCE	02	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-28-5211	TCGA-28-5211-D15038	57	-1	null	null	null	null	null	Temodar	null	01	140	mg	ADJUVANT	01	Oral	NO	Chemotherapy	null	8360	mg
TCGA-28-5211	TCGA-28-5211-D16144	307	244	null	null	null	null	null	CPT11	null	02	Unknown	null	RECURRENCE	02	null	NO	Chemotherapy	null	Unknown	null
TCGA-28-5211	TCGA-28-5211-D28881	57	-1	null	null	null	null	null	Temodar	null	01	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	8360	mg
TCGA-28-5211	TCGA-28-5211-D28882	307	244	null	null	null	null	null	Avastin	null	02	null	null	RECURRENCE	null	null	NO	Chemotherapy	null	null	null
TCGA-28-5211	TCGA-28-5211-D28883	307	244	null	null	null	null	null	CPT11	null	02	null	null	RECURRENCE	null	null	NO	Chemotherapy	null	null	null
TCGA-28-5213	TCGA-28-5213-D15020	null	11	null	null	null	null	null	Temodar	null	null	1800	mg/m2/day	ADJUVANT	null	Oral	YES	Chemotherapy	null	null	mg/kg/day
TCGA-28-5213	TCGA-28-5213-D28887	null	11	null	null	null	null	null	Temodar	null	null	140	mg/m2/day	ADJUVANT	null	Oral	YES	Chemotherapy	null	null	mg/m2/day
TCGA-28-5214	TCGA-28-5214-D15533	null	262	null	null	null	null	null	Avastin	null	null	10	mg/kg	RECURRENCE	02	Intravenous (IV)	YES	Chemotherapy	null	null	null
TCGA-28-5214	TCGA-28-5214-D14984	null	20	null	null	null	null	null	Temodar	null	02	1750	mg/m2/day	ADJUVANT	01	Oral	YES	Chemotherapy	null	null	mg/m2/day
TCGA-28-5214	TCGA-28-5214-D16137	null	262	null	null	null	null	null	CPT 11	null	Uknown	Unknown	null	RECURRENCE	02	Intravenous (IV)	YES	Chemotherapy	null	null	null
TCGA-28-5214	TCGA-28-5214-D28891	null	20	null	null	null	null	null	Temodar	null	02	1750	mg/m2/day	ADJUVANT	null	Oral	YES	Chemotherapy	null	null	mg/m2/day
TCGA-28-5214	TCGA-28-5214-D28892	null	262	null	null	null	null	null	Avastin	null	null	10	mg/kg	RECURRENCE	null	Intravenous (IV)	YES	Chemotherapy	null	null	mg/kg
TCGA-28-5214	TCGA-28-5214-D28893	null	262	null	null	null	null	null	CPT 11	null	null	null	null	RECURRENCE	null	Intravenous (IV)	YES	Chemotherapy	null	null	null
TCGA-28-5215	TCGA-28-5215-D15535	null	null	null	null	null	null	null	Avastin	null	Uknown	Unknown	null	RECURRENCE	02	Intravenous (IV)	null	Chemotherapy	null	Unknown	null
TCGA-28-5215	TCGA-28-5215-D14980	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-28-5215	TCGA-28-5215-D28898	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-28-5215	TCGA-28-5215-D28899	null	null	null	null	null	null	null	null	null	null	null	null	RECURRENCE	null	Intravenous (IV)	null	Chemotherapy	null	null	null
TCGA-28-5216	TCGA-28-5216-D14978	70	29	null	null	null	null	null	Temodar	null	10	140	mg	ADJUVANT	01	Oral	NO	Chemotherapy	null	5880	mg
TCGA-28-5216	TCGA-28-5216-D28903	70	29	null	null	null	null	null	Temodar	null	10	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-28-5218	TCGA-28-5218-D14973	null	68	null	null	null	null	null	Temodar	null	null	100	mg	ADJUVANT	01	Oral	NO	Chemotherapy	null	null	null
TCGA-28-5218	TCGA-28-5218-D28907	null	68	null	null	null	null	null	Temodar	null	null	100	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-28-5219	TCGA-28-5219-D14963	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-28-5219	TCGA-28-5219-D28911	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-28-5220	TCGA-28-5220-D14968	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-28-5220	TCGA-28-5220-D28915	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	null	null	Chemotherapy	null	null	null
TCGA-28-6450	TCGA-28-6450-D15046	41	25	null	null	null	null	null	Temozolomide	null	03	123	mg	ADJUVANT	01	Oral	NO	Chemotherapy	null	2125	mg
TCGA-28-6450	TCGA-28-6450-D28919	41	25	null	null	null	null	null	Temoxolomide	null	03	125	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	2125	mg
TCGA-32-1970	TCGA-32-1970-C1	67	28	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	NO	null	null	6800	mg
TCGA-32-1970	TCGA-32-1970-C2	null	null	null	null	null	CHEMO	null	Temodar	null	null	null	null	ADJUVANT	null	ORAL	null	null	null	null	mg
TCGA-32-1973	TCGA-32-1973-D27725	542	521	null	null	null	null	null	BIBW2992	null	1	null	null	null	null	Oral	NO	Chemotherapy	null	null	null
TCGA-32-1973	TCGA-32-1973-D27726	542	521	null	null	null	null	null	Temodar	null	1	150	mg	null	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-32-1973	TCGA-32-1973-D27727	64	22	null	null	null	null	null	Temodar	null	null	300	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-32-1973	TCGA-32-1973-D27728	417	99	null	null	null	null	null	Temodar	null	12	390	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-32-1973	TCGA-32-1973-D27729	631	549	null	null	null	null	null	Avastin	null	6	949	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-32-1973	TCGA-32-1973-D27730	631	549	null	null	null	null	null	Irinotecan	null	6	125	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	null	null
TCGA-32-1973	TCGA-32-1973-D27731	32	23	null	null	null	null	null	Metexafin Gadolinium	null	2	5	mg/kg	ADJUVANT	null	Intra-peritoneal (IP),Intravenous (IV)	NO	Chemotherapy	null	null	mg/kg
TCGA-32-1982	TCGA-32-1982-C1	null	null	null	null	null	CHEMO	null	Gliadel Wafer	null	null	null	null	OTHER: SPECIFY IN NOTES	null	null	null	null	null	null	{Wafer}
TCGA-32-1986	TCGA-32-1986-C2	139	126	null	null	null	CHEMO	null	Temodar	null	1.0	null	null	ADJUVANT	null	ORAL	NO	null	null	null	mg/day
TCGA-32-1987	TCGA-32-1987-D27747	66	26	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	120	mg/day
TCGA-32-1987	TCGA-32-1987-D27748	67	67	null	null	null	null	null	Gliadle Wafer	null	null	5	{Wafer}	null	null	null	NO	Chemotherapy	null	null	{Wafer}
TCGA-32-1987	TCGA-32-1987-D27749	133	129	null	null	null	null	null	Temodar	null	1	250	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-1987	TCGA-32-1987-D27750	null	211	null	null	null	null	null	Avastin	null	null	null	null	null	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg/kg
TCGA-32-1991	TCGA-32-1991-D27754	0	0	null	null	null	null	null	Gliadel wafer	null	null	5	{Wafer}	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	{Wafer}
TCGA-32-1991	TCGA-32-1991-D27755	65	22	null	null	null	null	null	Temodar	null	1	165	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-1991	TCGA-32-1991-D27756	98	94	null	null	null	null	null	Temodar	null	1	330	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-1991	TCGA-32-1991-D27757	341	124	null	null	null	null	null	Temodar	null	8	425	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-1991	TCGA-32-1991-D27758	98	94	null	null	null	null	null	Temodar	null	1	330	mg/day	ADJUVANT	null	null	NO	Chemotherapy	null	null	mg/day
TCGA-32-1991	TCGA-32-1991-D27759	65	23	null	null	null	null	null	Motexafin Gadolinium	null	06	05	mg/kg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg/kg
TCGA-32-2491	TCGA-32-2491-D27763	59	18	null	null	null	null	null	Temodar	null	null	160	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	6720	mg/m2
TCGA-32-2491	TCGA-32-2491-D27764	122	117	null	null	null	null	null	Temodar	null	1	200	mg/m2	null	null	Oral	NO	Chemotherapy	null	null	mg/m2
TCGA-32-2494	TCGA-32-2494-D27768	62	20	null	null	null	null	null	Temodar	null	null	140	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-32-2494	TCGA-32-2494-D27769	94	90	null	null	null	null	null	Temodar	null	1	270	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	150	mg/m2
TCGA-32-2494	TCGA-32-2494-D27770	403	120	null	null	null	null	null	Temodar	null	11	360	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-32-2494	TCGA-32-2494-D27771	550	488	null	null	null	null	null	Temodar	null	4	160	mg/day	null	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-2494	TCGA-32-2494-D27772	632	620	null	null	null	null	null	Temodar	null	1	140	mg/day	null	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-2494	TCGA-32-2494-D27773	550	488	null	null	null	null	null	Avastin	null	null	600	mg	null	null	Oral	NO	Targeted Molecular therapy	null	null	mg
TCGA-32-2494	TCGA-32-2494-D27774	620	620	null	null	null	null	null	Avastin	null	null	null	null	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	10	mg/kg
TCGA-32-2495	TCGA-32-2495-D27780	74	33	null	null	null	null	null	Temodar	null	1	140	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-32-2495	TCGA-32-2495-D27781	106	102	null	null	null	null	null	Temodar	null	1	290	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-32-2495	TCGA-32-2495-D27782	191	130	null	null	null	null	null	Temodar	null	3	380	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-32-2495	TCGA-32-2495-D27783	251	251	null	null	null	null	null	Gliadel Wafer	null	null	5	{Wafer}	null	null	null	NO	Chemotherapy	null	null	{Wafer}
TCGA-32-2495	TCGA-32-2495-D27784	428	278	null	null	null	null	null	Temodar	null	5	380	null	null	null	Oral	NO	Chemotherapy	null	null	null
TCGA-32-2615	TCGA-32-2615-D27789	65	26	null	null	null	null	null	Temodar	null	null	160	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	160	mg/day
TCGA-32-2615	TCGA-32-2615-D27790	0	0	null	null	null	null	null	Gliadel Wafer	null	null	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	{Wafer}
TCGA-32-2615	TCGA-32-2615-D27791	100	96	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	300	mg/day
TCGA-32-2615	TCGA-32-2615-D27792	273	161	null	null	null	null	null	Metronomic Temodar	null	4	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	155	mg/day
TCGA-32-2615	TCGA-32-2615-D27793	285	285	null	null	null	null	null	Gliadel Wafers	null	null	null	null	null	null	null	NO	Chemotherapy	null	null	{Wafer}
TCGA-32-2615	TCGA-32-2615-D27794	285	285	null	null	null	null	null	Gliadel Wafer	null	null	null	null	RECURRENCE	null	null	NO	Chemotherapy	null	null	null
TCGA-32-2615	TCGA-32-2615-D27795	null	301	null	null	null	null	null	Avastin	null	null	null	null	RECURRENCE	null	Intra-peritoneal (IP),Intravenous (IV)	YES	Targeted Molecular therapy	null	10	mg/kg
TCGA-32-2615	TCGA-32-2615-D27796	null	301	null	null	null	null	null	Bevacizumab Avastin	null	null	null	null	RECURRENCE	null	Intra-peritoneal (IP),Intravenous (IV)	YES	Targeted Molecular therapy	null	10	mg/kg
TCGA-32-2616	TCGA-32-2616-D30225	71	29	null	null	null	null	null	Temodar	null	null	75	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5590	mg
TCGA-32-2616	TCGA-32-2616-D30226	104	100	null	null	null	null	null	Temodar	null	1	270	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	1350	mg
TCGA-32-2616	TCGA-32-2616-D30227	160	128	null	null	null	null	null	Temodar	null	2	200	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	360	mg
TCGA-32-2616	TCGA-32-2616-D30228	51	30	null	null	null	null	null	Motexatin Gadoinium	null	null	null	null	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	50167	mg
TCGA-32-2634	TCGA-32-2634-D27801	59	17	null	null	null	null	null	Temodar	null	null	200	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	160	mg
TCGA-32-2634	TCGA-32-2634-D27802	0	0	null	null	null	null	null	Gliadel Wafer	null	null	null	null	null	null	null	NO	Chemotherapy	null	null	{Wafer}
TCGA-32-2634	TCGA-32-2634-D27803	null	108	null	null	null	null	null	Temodar	null	11	200	mg	null	null	Oral	YES	Chemotherapy	null	null	mg
TCGA-32-2638	TCGA-32-2638-D27807	68	26	null	null	null	null	null	Temozolomide	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	190	mg/day
TCGA-32-2638	TCGA-32-2638-D27808	114	110	null	null	null	null	null	Temozolomide	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	380	mg/day
TCGA-32-2638	TCGA-32-2638-D27809	133	49	null	null	null	null	null	Bevacizumab or placebo RTOG 0825	null	null	10	mg/kg	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	null	mg/kg
TCGA-32-4208	TCGA-32-4208-D27813	84	41	null	null	null	null	null	Temodar	null	1	140	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-4208	TCGA-32-4208-D27814	150	146	null	null	null	null	null	Temodar	null	null	300	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-4208	TCGA-32-4208-D27815	null	174	null	null	null	null	null	Temodar	null	null	300	mg/day	ADJUVANT	null	Oral	YES	Chemotherapy	null	null	mg/day
TCGA-32-4209	TCGA-32-4209-D15701	552	502	null	null	null	null	null	Avastin	null	04	10	mg/kg	null	03	Intravenous (IV)	NO	Targeted Molecular therapy	null	400	mg
TCGA-32-4209	TCGA-32-4209-D15702	531	502	null	null	null	null	null	CCNU	null	02	100	mg/kg	null	02	Oral	NO	Chemotherapy	null	200	mg
TCGA-32-4209	TCGA-32-4209-D27819	85	41	null	null	null	null	null	Temodar	null	1	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-32-4211	TCGA-32-4211-D27825	64	24	null	null	null	null	null	Temodar	null	1	160	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-4211	TCGA-32-4211-D27826	96	92	null	null	null	null	null	Temodar	null	1	330	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-4211	TCGA-32-4211-D27827	130	126	null	null	null	null	null	Temodar	null	1	440	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg/day
TCGA-32-4213	TCGA-32-4213-D15679	null	560	null	null	null	null	null	Avastin	null	04	944	mg	null	04	Intravenous (IV)	YES	Targeted Molecular therapy	null	3776	mg
TCGA-32-4213	TCGA-32-4213-D27831	107	24	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	130	mg/day
TCGA-32-4213	TCGA-32-4213-D27832	134	129	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	390	mg/day
TCGA-32-4213	TCGA-32-4213-D27833	288	154	null	null	null	null	null	Temodar	null	5	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	400	mg/day
TCGA-32-4719	TCGA-32-4719-D27838	69	30	null	null	null	null	null	Temodar	null	null	140	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	75	mg/m2
TCGA-32-4719	TCGA-32-4719-D27839	244	87	null	null	null	null	null	Temodar	null	6	380	mg/m2	ADJUVANT	null	Oral	NO	Chemotherapy	null	200	mg/m2
TCGA-32-5222	TCGA-32-5222-D27843	77	33	null	null	null	null	null	Temodar	null	4	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5880	mg
TCGA-41-2571	TCGA-41-2571-D27981	25	22	null	null	null	null	null	Temodar	null	1	160	mg	PALLIATIVE	null	Oral	NO	Chemotherapy	null	640	mg
TCGA-41-2572	TCGA-41-2572-D27984	351	133	null	null	null	null	null	Bevacizumab	null	13	1200	mg	null	null	Intravenous (IV)	NO	Chemotherapy	null	15600	mg
TCGA-41-2572	TCGA-41-2572-D27985	76	34	null	null	null	null	null	Temodar	null	null	180	mg	null	null	Oral	NO	Targeted Molecular therapy	null	7740	mg
TCGA-41-2573	TCGA-41-2573-D27990	71	29	null	null	null	null	null	Temodar	null	1	160	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6720	mg
TCGA-41-2573	TCGA-41-2573-D27991	142	100	null	null	null	null	null	Temodar	null	1	160	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6880	mg
TCGA-41-2573	TCGA-41-2573-D27992	142	127	null	null	null	null	null	BSI-201	null	null	null	null	ADJUVANT	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	null	null
TCGA-41-2573	TCGA-41-2573-D27993	null	171	null	null	null	null	null	Avastin	null	null	10	mg/kg	null	null	Intravenous (IV)	YES	Targeted Molecular therapy	null	null	mg/kg
TCGA-41-2575	TCGA-41-2575-D27997	145	95	null	null	null	null	null	Temodar	null	1	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	7140	mg
TCGA-41-2575	TCGA-41-2575-D27998	166	166	null	null	null	null	null	Avastin	null	null	800	mg	null	null	Intravenous (IV)	NO	Targeted Molecular therapy	null	800	mg
TCGA-41-3393	TCGA-41-3393-D28005	95	51	null	null	null	null	null	Temodar	null	1	120	mg	null	null	Oral	NO	Chemotherapy	null	5040	mg
TCGA-41-3915	TCGA-41-3915-D15059	289	201	null	null	null	null	null	temodar	null	04	400	mg	ADJUVANT	02	Oral	NO	Chemotherapy	null	8000	mg
TCGA-41-3915	TCGA-41-3915-D28009	70	26	null	null	null	null	null	Temodar	null	1	160	mg	null	null	Oral	NO	Chemotherapy	null	6880	mg
TCGA-41-3915	TCGA-41-3915-D28010	null	114	null	null	null	null	null	Temodar	null	3	320	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	5200	mg
TCGA-41-5651	TCGA-41-5651-D19527	387	359	null	null	null	null	null	Avastin	null	03	850	mg	RECURRENCE	04	Intravenous (IV)	NO	Targeted Molecular therapy	null	2550	mg
TCGA-41-5651	TCGA-41-5651-D28016	77	31	null	null	null	null	null	Temozolomide	null	01	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6580	mg
TCGA-41-5651	TCGA-41-5651-D28017	195	105	null	null	null	null	null	Temozolomide	null	04	350	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6600	mg
TCGA-41-5651	TCGA-41-5651-D28018	null	231	null	null	null	null	null	Gliadel wafer carmustine	null	01	null	null	RECURRENCE	null	null	NO	Chemotherapy	null	null	{Wafer}
TCGA-41-5651	TCGA-41-5651-D28019	null	345	null	null	null	null	null	Avastin	null	null	800	mg	RECURRENCE	null	Intravenous (IV)	YES	Targeted Molecular therapy	null	800	mg
TCGA-41-6646	TCGA-41-6646-D28023	80	39	null	null	null	null	null	Temozolomide	null	01	160	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	6720	mg
TCGA-41-6646	TCGA-41-6646-D28024	195	111	null	null	null	null	null	Temozolomide	null	03	320	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	5600	mg
TCGA-74-6573	TCGA-74-6573-D16945	66	24	null	null	null	null	null	Temozolomide	null	01	140	mg/day	ADJUVANT	01	Oral	NO	Chemotherapy	null	6020	mg
TCGA-74-6575	TCGA-74-6575-D16931	73	36	null	null	null	null	null	Temozolomide	null	01	120	mg/day	ADJUVANT	01	Oral	NO	Chemotherapy	null	4560	mg
TCGA-74-6575	TCGA-74-6575-D16933	130	96	null	null	null	null	null	Temozolomide	null	02	200	mg/day	RECURRENCE	02	Oral	NO	Chemotherapy	null	2000	mg
TCGA-74-6575	TCGA-74-6575-D16934	497	151	null	null	null	null	null	Avastin	null	01	5	mg/kg	RECURRENCE	03	Intravenous (IV)	NO	Targeted Molecular therapy	null	255	mg/kg
TCGA-74-6575	TCGA-74-6575-D16936	null	497	null	null	null	null	null	Avastin	null	01	10	mg/kg	RECURRENCE	04	Intravenous (IV)	YES	Targeted Molecular therapy	null	Unknown	mg/kg
TCGA-74-6577	TCGA-74-6577-D16924	98	54	null	null	null	null	null	Temozolomide	null	01	140	mg/day	ADJUVANT	01	Oral	NO	Chemotherapy	null	6300	mg
TCGA-74-6577	TCGA-74-6577-D16926	null	131	null	null	null	null	null	Avastin	null	01	10	mg/kg	null	02	Intravenous (IV)	YES	Targeted Molecular therapy	null	Unknown	mg/kg
TCGA-74-6581	TCGA-74-6581-D16910	74	26	null	null	null	null	null	Temozolomide	null	01	150	mg/day	ADJUVANT	01	Oral	NO	Chemotherapy	null	7350	mg
TCGA-74-6581	TCGA-74-6581-D16911	null	94	null	null	null	null	null	Temozolomide	null	06	200	mg/m2/day	ADJUVANT	02	Oral	YES	Chemotherapy	null	6000	mg/m2
TCGA-74-6584	TCGA-74-6584-D16903	65	21	null	null	null	null	null	Temozolomide	null	01	150	mg/day	ADJUVANT	01	Oral	NO	Chemotherapy	null	6750	mg
TCGA-74-6584	TCGA-74-6584-D16904	null	97	null	null	null	null	null	Avastin	null	11	10	mg/m2	null	01	Intravenous (IV)	YES	Targeted Molecular therapy	null	110	mg/m2
TCGA-74-6584	TCGA-74-6584-D16905	null	98	null	null	null	null	null	Temozolomide	null	05	120	mg/day	null	02	Oral	YES	Chemotherapy	null	12600	mg
TCGA-76-4925	TCGA-76-4925-D28520	150	null	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-76-4926	TCGA-76-4926-D28524	115	83	null	null	null	null	null	Temodar	null	02	null	null	ADJUVANT	null	null	NO	Chemotherapy	null	null	null
TCGA-76-4928	TCGA-76-4928-D28530	70	null	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-76-4931	TCGA-76-4931-D28536	null	null	null	null	null	null	null	Temodar	null	null	null	null	RECURRENCE	null	Oral	null	Chemotherapy	null	null	mg
TCGA-76-4932	TCGA-76-4932-D28540	null	null	null	null	null	null	null	Temodar (escalation)	null	null	null	null	null	null	Oral	null	Chemotherapy	null	null	mg
TCGA-76-4935	TCGA-76-4935-D28546	null	175	null	null	null	null	null	Temodar	null	null	250	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	null	mg
TCGA-76-4935	TCGA-76-4935-D28547	null	0	null	null	null	null	null	Avastin	null	null	10	mg	ADJUVANT	null	Intravenous (IV)	YES	Chemotherapy	null	590	mg
TCGA-76-6191	TCGA-76-6191-D28551	423	24	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-76-6191	TCGA-76-6191-D28552	423	268	null	null	null	null	null	Avastin	null	null	10	mg/kg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	null	mg/kg
TCGA-76-6192	TCGA-76-6192-D28558	75	null	null	null	null	null	null	Temodar	null	01	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-76-6193	TCGA-76-6193-D28562	null	0	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	null
TCGA-76-6280	TCGA-76-6280-D30215	null	27	null	null	null	null	null	Temodar	null	null	150	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-76-6282	TCGA-76-6282-D28566	213	24	null	null	null	null	null	Temodar	null	null	210	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-76-6282	TCGA-76-6282-D28567	374	320	null	null	null	null	null	Avastin	null	6	890	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	5340	mg
TCGA-76-6285	TCGA-76-6285-D28571	null	null	null	null	null	null	null	Temodar	null	null	250	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-76-6286	TCGA-76-6286-D28574	null	101	null	null	null	null	null	Temodar	null	null	100	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-76-6286	TCGA-76-6286-D28575	579	509	null	null	null	null	null	Avastin	null	06	990	mg	null	null	Intravenous (IV)	NO	Chemotherapy	null	5940	mg
TCGA-76-6656	TCGA-76-6656-D28580	null	11	null	null	null	null	null	Temodar	null	null	140	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-76-6657	TCGA-76-6657-D28584	null	null	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-76-6661	TCGA-76-6661-D28588	114	48	null	null	null	null	null	Temodar	null	null	null	null	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-76-6662	TCGA-76-6662-D30220	226	87	null	null	null	null	null	Temodar	null	null	100	mg	ADJUVANT	null	Oral	NO	Chemotherapy	null	null	mg
TCGA-76-6662	TCGA-76-6662-D30221	null	253	null	null	null	null	null	Carmustine	null	04	360	mg	null	null	Intravenous (IV)	YES	Chemotherapy	null	1440	mg
TCGA-76-6663	TCGA-76-6663-D28592	null	43	null	null	null	null	null	Temodar	null	null	320	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	null	mg
TCGA-76-6663	TCGA-76-6663-D28593	174	92	null	null	null	null	null	ICT-107	null	null	null	null	ADJUVANT	null	null	NO	Immunotherapy	null	null	null
TCGA-76-6664	TCGA-76-6664-D28597	null	6	null	null	null	null	null	Temodar	null	null	250	mg	ADJUVANT	null	Oral	YES	Chemotherapy	null	null	mg
TCGA-76-6664	TCGA-76-6664-D28598	222	42	null	null	null	null	null	Avastin	null	14	510	mg	ADJUVANT	null	Intravenous (IV)	NO	Chemotherapy	null	7470	mg
TCGA-81-5911	TCGA-81-5911-D28603	68	21	null	null	null	null	null	Temodar	null	1	160	mg/day	RECURRENCE	null	Oral	NO	Chemotherapy	null	6720	mg/day
TCGA-81-5911	TCGA-81-5911-D28604	259	129	null	null	null	null	null	Temodar	null	05	440	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	11000	mg/day
TCGA-81-5911	TCGA-81-5911-D28605	107	103	null	null	null	null	null	Temodar	null	01	330	mg/day	ADJUVANT	null	Oral	NO	Chemotherapy	null	1650	mg/day
